Next Article in Journal
Antibacterial and Antiproliferative Activities of Azadirachta indica Leaf Extract and Its Effect on Oil-in-Water Food Emulsion Stability
Previous Article in Journal
Mechanical Constraint Effect on DNA Persistence Length
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Natural Reno-Protective Agents against Cyclosporine A-Induced Nephrotoxicity: An Overview

by
Sabrin R. M. Ibrahim
1,2,*,
Hossam M. Abdallah
3,4,
Ali M. El-Halawany
4,
Gamal A. Mohamed
3,
Aisha A. Alhaddad
5,
Waad A. Samman
5,
Ali A. Alqarni
3,6,
Akaber T. Rizq
3,
Kholoud F. Ghazawi
7 and
Riham Salah El-Dine
4
1
Preparatory Year Program, Department of Chemistry, Batterjee Medical College, Jeddah 21442, Saudi Arabia
2
Department of Pharmacognosy, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt
3
Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
4
Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt
5
Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Al-Madinah Al-Munawwarah 30078, Saudi Arabia
6
Pharmaceutical Care Department, Ministry of National Guard—Health Affairs, Jeddah 22384, Saudi Arabia
7
Clinical Pharmacy Department, College of Pharmacy, Umm Al-Qura University, Makkah 24382, Saudi Arabia
*
Author to whom correspondence should be addressed.
Molecules 2022, 27(22), 7771; https://doi.org/10.3390/molecules27227771
Submission received: 17 October 2022 / Revised: 6 November 2022 / Accepted: 7 November 2022 / Published: 11 November 2022

Abstract

:
CA (cyclosporine A) is a powerful immunosuppressing agent that is commonly utilized for treating various autoimmune illnesses and in transplantation surgery. However, its usage has been significantly restricted because of its unwanted effects, including nephrotoxicity. The pathophysiology of CA-induced kidney injury involves inflammation, apoptosis, tubular injury, oxidative stress, and vascular injury. Despite the fact that exact mechanism accountable for CA’s effects is inadequately understood, ROS (reactive oxygen species) involvement has been widely proposed. At present, there are no efficient methods or drugs for treating CA-caused kidney damage. It is noteworthy that diverse natural products have been investigated both in vivo and in-vitro for their possible preventive potential in CA-produced nephrotoxicity. Various extracts and natural metabolites have been found to possess a remarkable potential for restoring CA-produced renal damage and oxidative stress alterations via their anti-apoptosis, anti-inflammatory, and antioxidative potentials. The present article reviews the reported studies that assess the protective capacity of natural products, as well as dietary regimens, in relation to CA-induced nephrotoxicity. Thus, the present study presents novel ideas for designing and developing more efficient prophylactic or remedial strategies versus CA passive influences.

1. Introduction

The kidneys are vital organs that play an important role in removing waste and toxic materials from the blood, maintain electrolyte balance, and regulate the homeostasis of blood plasma, blood volume, blood pressure, and red blood cell genesis. The kidneys can be damaged or may become totally inactive due to several factors, such as oxidative stress, inflammation, ischemia/reperfusion injury, diabetes, and nephrotoxic agents, most often various modern drugs that are in use at present [1]. Just as some natural products are a source of substances that protect the kidneys, there are several plants known for their harmful effects on the kidneys, leading to renal dysfunction, ranging from acute to chronic renal failure and death. The herbal medicines mostly associated with nephrotoxicity are: Dioscorea quinqueloba, Lawsonia inermis, Cassia senna L., Artemisia herba-alba, Chenopodium polyspermum, Cape aloes, Euphorbia paralias, Crataegus orientalis, Colchicum autumnale, and Tribulus terrestris [2]. Additionally, in Persian medicine, a total of 64 plants that cause kidney damage have been reported, out of which Allium schoenoprasum and Marrubium vulgare were the most common nephrotoxic plants, but without relevant scientific evidence. Asafetida, garlic, saffron, and wormwood have been reported for their therapeutic effects on the kidneys, in addition to their kidney-damaging potential. Meanwhile, Cymbopogon citratus, Amaranthus spp., and Artemisia absinthium have been known to cause a direct nephrotoxic effect [3]
Nephrotoxicity is the condition in which the kidneys cannot properly detoxify and excrete drugs and toxic chemicals due to their destruction or damage caused by endo- or exogenous toxicants [4]. This is distinguished by increasing serum creatinine and urea and reducing the rate of GFR (glomerular filtration), and may be accompanied by arterial hypertension. Histologically, renal pathological changes occur, such as the swelling of the tubular cells, necrosis, arterial changes, and interstitial fibrosis [5]. Nephrotoxicity is frequently caused by a variety of drugs and chemicals, or environmental pollutants. Drugs cause approximately twenty five percent of nephrotoxicity, which can increase up to 66% in elderly people [6].
Cyclosporine A (CA), a cyclic peptide consisting of eleven amino acids, is purified from Topocladium inflatum fungus. CA is a potent immuno-suppressive agent that is commonly utilized to prohibit transplanted-organ rejection [7]. In solid-organ transplantation, CA significantly improves long-term survival rates [8]. Moreover, CA is utilized to manage varied autoimmune disorders, such as rheumatoid arthritis, psoriasis, and nephritic syndrome, as well as dermatological disorders [9]. However, CA has a narrow therapeutic index and its metabolism is performed by hepatic cytochrome (CYP450 3A 4/5) [10]. Nephrotoxicity is one of the serious adverse effects that limit the therapeutic uses of CA. Several reports have discussed the mechanisms by which CA induces nephrotoxicity [11,12]. The CA-nephrotoxicity-involved mechanism has not yet been completely elucidated. In 2017, a report by Lai et al. indicated that CA mediated renal damage through many mechanisms, involving the generation of inflammation, oxidative stress (OS), autophagy, and apoptosis [13] (Figure 1).
Numerous evidence reveals that ROS overproduction and OS have a definitive role in CA renal pathogenesis [13,14,15]. Briefly, CA promotes endoplasmic reticulum stress and increases the production of mitochondrial ROS (reactive oxygen species), resulting in redox balance alteration, which causes lipid peroxidation (Figure 2) [11].
It has been reported that diverse signaling pathways take part in CA-nephrotoxicity pathogenesis, such as ERK, p38, and JNK, whereas NF-κB represents a CA-target molecule. Moreover, Nrf2 regulates the cellular oxidative stress induced by CA, while renal fibrosis produced by CA is attributed to TGF-β1 (transforming growth-factor-b1) [11,16]. Generally, CA weakens endothelium-based relaxation and prohibits the synthesis of nitric oxide in the renal artery. The nephrotoxic effect of CA is exerted by targeting the epithelial cells of renal tubules and stimulates the EMT (epithelial–mesenchymal transition) in these cells, leading to inflammation-mediated fibrosis and finally kidney failure [17,18]. Moreover, it suppresses DNA synthesis and induces apoptosis in these cells [19]. Shi et al. stated that CA stimulates the production of vasoconstriction factors, such as ROS, RNS (reactive nitrogen species), TGF-β1, NO, angiotensin II, leukotriene, and thromboxane A2 [20]. Moreover, Wirestam et al. reported that CA can indirectly damage renal tubular cells via stimulating osteopontin production, which leads to injuring the renal cells [21]. Therefore, the strategy used to date for overcoming CA is either reducing its dosage or using a combination of CA and another drug. It is noteworthy that various natural metabolites are reported to have the capacity to ameliorate CA-mediated renal toxicity, such as phenolics, polysaccharides, and terpenoids. Thus, the rational use of natural products could assist in minimizing the toxicity of this drug. The current review mainly focuses on natural products that are capable of reducing CA-induced nephrotoxicity. This review introduces a positive perception of the role of natural products in the amelioration of CA-induced nephrotoxicity, thereby amending the treatment strategies for patients who receive CA and their possible implications for natural supplements or drug combinations. The literature was searched using different databases and publishers: Scopus, PubMed, Springer, Google-Scholar, MDPI, Elsevier, Wiley, Bentham, and JACS. The keywords utilized for the search included natural product + cyclosporine A + nephrotoxicity; reno-protective + natural products + cyclosporine A-induced nephrotoxicity; and natural product + nephro-protection + cyclosporine A. No time limit for the publication date was set. A total of 108 articles are reviewed in this study. All the reported studies evaluating the effectiveness of potential natural reno-protective agents on CA-caused nephrotoxicity are summarized.

2. Phytoconstituents Prevent CA-Induced Nephrotoxicity

Different classes of phytochemicals were proved to improve the nephrotoxicity accompanying the use of cyclosporins (Figure 3).

2.1. Phenolics and Polyphenols

2.1.1. Catechin

Catechin is a flavanol widely available in many foods and herbal products, especially in green tea extract (Table 1). Recent studies revealed that catechin has a dose-dependent nephro-protective effect on CA-induced nephrotoxicity [22]. The administration of CA in a dose of 20 mg/kg/day for twenty-one days markedly affected renal function, as indicated by the increase in renal creatinine and urea levels in rats. Catechin (100 mg/kg/day) co-administered with CA significantly ameliorated the nephrotoxic effect of CA as indicated by enhanced renal functions. On the other hand, lower doses of catechin (50 mg/kg/day) presented a milder protective effect than higher doses of the compound [22]. The prophylactic mechanism of catechin on CA-induced renal toxicity may be due to its antioxidant effect. Oxidative parameters, such as increased lipid peroxidation, decreased glutathione and superoxide dismutase levels, and increased catalase levels, were detected in rat kidney homogenate upon a chronic administration of CA. The co-administration of catechin (50 and 100 mg/Kg/day) with CA markedly enhanced all the previously mentioned oxidative stress parameters in a dose-dependent manner [22].

2.1.2. Epigallocatechin Gallate (EGCG)

EGCG is the most abundant catechin derivative in green tea with marked antioxidant and anti-inflammatory activities. It also has a prophylactic effect on neurodegenerative diseases and diabetes [38]. Similar to catechin, EGCG provides a significant protective effect on CA-induced nephrotoxicity mediated by its antioxidative effect [39]. Despite its biological activities, it has a poor pharmacokinetic property upon oral administration due to its unstable alkaline PH, poor intestinal permeability, and extensive pre-systemic metabolism. Italia et al. compared the effect of an EGCG nanoparticulate formulation on CA-induced nephrotoxicity in rats, in both orally and intraperitoneally administered compounds. I.P. (intra-peritoneal)-administered pure EGCG presented a significant protective effect, while the activity was diminished through the oral administration of the compound (Table 2). On the other hand, the oral administration of an EGCG nano-formulation presented a nephro-protective effect similar to that of an I.P.-administered drug due to its improved pharmacokinetic properties [38].

2.1.3. Naringin

Naringin is a flavanone glycoside that mainly occurs in citrus fruits (Rutaceae), especially grapefruit. It has been reported that naringin is an effective reno-protective agent against CA-induced nephrotoxicity. Naringin can significantly decrease free-radical levels, including OH and lipid peroxidation, and increase antioxidant enzyme (e.g., SOD, GPx, and catalase) activity in renal tissues. Moreover, it can restore non-enzymatic antioxidants (GSH and vitamins C, E, and A). Additionally, it ameliorates the degeneration damage to kidneys induced by CA. Furthermore, the expression of HO-1 is maintained during naringin treatment, which may be the major reason for reno-protection [29].

2.1.4. Silibinin

Silibinin is one of the major flavonolignans in the hepatoprotective drug silymarin, with reported antioxidant activity and an inhibition of rat microsome lipid peroxidation. The effect of the administration of silibinin with CA on malondialdehyde levels in blood and kidney homogenate, in addition to the level of cytochrome p450, an enzyme that metabolizes CA into inactive metabolites, in microsomal liver suspension were estimated. MDA and creatinine levels were returned to normal by the co-administration of silibinin with CA. Interestingly, silibinin administration did not affect the glomerular filtration rate, but markedly increased cytochrome p450 levels compared to the CA group, suggesting its effect on cyclosporine biotransformation in the liver [47].

2.1.5. Ellagic Acid

Ellagic acid is a known phenolic constituent of many fruits and nuts, such as raspberries, strawberries, grapes, and walnuts [51]. It has been reported to present anti-oxidant, anticancer, anti-inflammatory, and antimutagenic effects through its potent free-radical scavenging activity. The subcutaneous administration of ellagic acid (10 mg/kg) revealed a marked protective effect on liver and kidney functions compared to the CA group. Ellagic acid normalized MDA, catalase, and glutathione levels when co-administered with CA. These biochemical results were confirmed further through histopathological investigations [46]. This activity seemed to be dependent on the antioxidant activities of ellagic acid.

2.1.6. Caffeic Acid Phenethyl Ester

Caffeic acid phenethyl ester (CAPE) is a natural phenolic compound formed by the esterification of caffeic acid with phenethyl alcohol. It represents a major component of propolis obtained from honeybees. CA-induced nephrotoxicity produced lipid peroxidation, MPO, SOD, and CAT activities in renal tissue. CAPE prevented an increase in MDA, but increased CAT and did not affect MPO and SOD. Therefore, CAPE may be an efficient agent to protect the kidneys from CA-induced damage via the inhibition of lipid peroxidation [36].

2.1.7. Resveratrol

Resveratrol is a polyphenolic compound that represents a major constituent in red grapes (Vitis vinifera, Vitaceae) [52]. It is known for its anti-oxidant, anti-inflammatory, anti-glycation, hepatoprotective, and anti-cancer properties. Moreover, it can improve hyperglycemia, hyperlipidemia, and diabetic complications. A study conducted by Chander et al. revealed that at doses of 5 and 10 mg/kg, resveratrol was able to improve renal dysfunction and renal and tissue nitric oxide levels, as well as renal oxidative stress. This protective effect was proved to be NO-dependent [37].

2.1.8. Provinol

Provinol is a mixture of polyphenolic compounds extracted from French red wine, involving (in mg/g of dry powder) 480 proanthocyanidins, 370 polymeric tannins, 61 total anthocyanins, 19 free anthocyanins, 38 catechins, 18 hydroxycinnamic acids, and 14 flavonols [53]. Provinol was observed to protect against CA-induced renal toxicity due to the antioxidant activity of its phenolic content [49,54]. However, the anti-apoptotic effect of phenolics on renal cells was clarified further in rats treated with CA, provinol, and a combination of both drugs for 21 days. CA markedly increased systolic blood pressure, decreased body weight, and increased serum creatinine and total protein levels. The administration of provinol with CA markedly protected the rats from nephrotoxicity, as indicated by the enhanced biochemical parameters. In addition, the CA group revealed alterations in and the translocation of Bax and cytochrome c levels from cytoplasm to mitochondria that activated the caspase-mediated apoptotic pathway. Provinol markedly inhibited this apoptotic cascade, which was concluded to be the reason for its nephro-protective effect [50]. Provinol could ameliorate a reduction in body weight and increased systolic blood pressure induced by rat treatment with CA. It also exerted a reduction in oxidative stress and iNOS expression via the NF-kB pathway [53].

2.1.9. Curcumin

Curcumin is a diarylheptanoid that represents a major active compound in the rhizomes of Curcuma longa (Zingiberaceae). It is traditionally recommended in the treatment of biliary and hepatic disorders and rheumatism. Previous biological studies proved its powerful antioxidant, anti-inflammatory, and antiviral effects. Curcumin proved to present a significant protective effect against CA-induced nephrotoxicity in rats based on its ability to modify all histological changes and antioxidant effects via GST immuno-expression, decreasing TBARS and increasing levels of antioxidant enzymes (GSH, SOD, and CAT) [33,45]. Moreover, it was able to decrease serum creatinine levels and BUN, and improve creatinine clearance [44]. In another study, the treatment of HK-2 human renal cells with CA and different doses of curcumin [44] caused a dose-dependent reduction in ROS and MDA levels, in addition to increasing SOD, GSH-Px, and CAT levels. Moreover, it increased Bcl-2 and decreased Bax protein in HK-2 cells. Moreover, in vitro and in silico studies proved the ability of curcumin to ameliorate genotoxicity as well as DNA damage produced by the long-term use of CA [55]. The mechanism of this effect is based on the ability of curcumin to indirectly induce the expression of different anti-oxidant enzymes. Additionally, curcumin activated Nrf2-Keap1 that is responsible for the free-radical eradication from tissues through the expression of detoxifying enzymes [55].

2.2. Lignan Derivatives

Schisandrin B (ScB), a lignan derivative, was separated from Schisandra chinensis. This plant displayed beneficial values in treating hepatitis and regulating renal function [13]. Its extract had protective potential against nephrotoxicity caused by CA in rats [25]. ScB was reported to have a protective effect against cisplatin, gentamicin, and mercury-mediated nephrotoxicity [56,57,58] in rats. In a study on HK-2, the cyto-protective influence of ScB towards the CA nephrotoxic effect by assessing different parameters, such as LDH, GSH, ROS, and ΔΨm (mitochondrial membrane potential), as well as apoptosis and autophagy, was investigated [13]. It was revealed that the pre-incubation of HK-2 cells with ScB (2.5–10.0 μM) alleviated the cytotoxicity caused CA because of OS, as it reduced ROS and LDH levels and increased ΔΨm and GSH. Furthermore, it stimulated the translocation of Nrf2 into the nucleus and downstream HO-1, NQO1, and GCLM gene expressions, as well as reducing the apoptosis rate and recovering the blocked auto-phagic flux induced by CA. Therefore, ScB has a remarkable role in prohibiting CA-provoked OS, autophagy, and apoptosis by promoting cell survival through ROS scavenging [13]. Another study conducted by Zhu et al. in 2012 to assess the effect of ScB on CA produced renal toxicity both in vivo and in vitro. ScB (20 mg/kg/day, gavage followed by CA 30 mg/kg/day, SC for 28 days) significantly repressed the increase in serum creatinine and BUN levels, and improved the kidney structure alteration caused by CA in mice. ScB also reversed the CA negative effects, as indicated by decreasing renal MDA levels and increasing GSH levels. In vitro, Sch B (2.5, 5, and 10 µM) prominently increased HK-2 cell viability and decreased apoptosis and the release of LDH provoked by CA (10 µM), as well as increased ATP and GSH intracellular levels and attenuated ROS generation induced by CA. It is noteworthy that the reduction in OS and cell death rates was proposed to be the reason for ScB’s protective effect [41].

2.3. Carotenoids

LYC (lycopene), a carotenoid, is accountable for the pink-to-red colors of grapefruits, tomatoes, and other foods. It presents a protective influence against various chronic disorders, such as skin, prostate, and lung cancers, as well as degenerative and cardiovascular diseases [59]. LYC is known to have a potent ROS-quenching power and protects DNA, proteins, and lipids against oxidation in vivo [60,61]. It has a protective effect on gentamicin-induced renal damage in rats [62]. Gado et al. conducted a study that revealed the protective effect of LYC (40 mg/kg/day/p.o. for 5 days before and 10 days concomitant with CA) against nephrotoxicity induced by CA. The results show that LYC significantly reduces creatinine and urea serum levels and restores GSH content, as well as prohibits MDA elevation and increases SOD and GSH-Px activities. A histological investigation revealed the amelioration of nephritis and tubular necrosis in comparison with the CA group. LyC alleviated kidney impairment caused by the CA oxidative stress mechanism due to its antioxidant potential [26]. In another investigation, performed in 2007, Ateșșahin et al. evaluated the renal protective action of LYC (10 mg/kg/day for 21 days) in the renal damage and oxidative stress caused by CA in rats, as indicated by the increase in plasma urea and creatinine levels, as well as increased TBARS and GSH and decreased CAT and GSH-Px activities. Moreover, degeneration, tubular necrosis, dilatation, formation of luminal cast, thickened basement membranes, and inter-tubular fibrosis were observed in CA-intoxicated rats. LYC treatment ameliorated the CA reno-toxic effect via decreased plasma urea and creatinine concentrations and elevated TBARs levels while it increased GSH-Px and CAT activity. Moreover, it restored the pathological alteration produced by CA in the kidneys [42].

2.4. Organo-Sulfur Derivatives

S-allylcysteine (SAC), an organo-sulfur constituent of aged Allium sativum, exhibits antioxidant, anti-cancer, neuro-trophic, hepato-, and cardio-protective properties via its antioxidant potential [63]. It was stated that SAC is able to scavenge H2O2 and O2, thus prohibiting H2O2-induced endothelial cell damage, LPO, and LDL low-density lipoprotein oxidation [27]. In 2008, Magendiramani et al. investigated the protective potential of an SAC (100 mg/kg/day, I.P.) co-injection on AC (25 mg/kg/day, I.P.)-induced nephrotoxicity in a rat. The results indicate a marked elevation in uric acid, urea, and creatinine serum levels and LPO together with abnormal antioxidant (non-enzymatic; vit. E and C and GSH, and enzymatic CAT, GPx, SOD, and GR) levels in the CA group in comparison to the control group. Their results reveal that SAC significantly attenuates peroxidative levels and boosts the antioxidant status along with reducing iNOS, MMP-2, and NF-kB elevated levels because of CA. Moreover, it decreases the observed increase in uric acid, urea, and creatinine levels, as well as inflammation and renal injury in CA-treated rats [27].

2.5. Terpenoids

Thymoquinone (TQ), a component of Nigella sativa oil, has anti-hyperglycemic, nephro- and hepato-protective, anti-inflammatory, hypolipidemic, and anti-neoplastic activities. It prohibits CYP3A that is accountable for metabolizing most drugs [64]. Alrashedia et al., in a study performed in 2018, revealed that TQ (orally, 10 mg/kg, 7 days) reduced the bioavailability of oral CA (10 mg/kg, 5 days) and had no effect on the bioavailability of IP-administered CA (10 mg/kg, 5 days, 1 hr after TQ) in rats because of the induction of intestinal first-pass metabolism by TQ, which in turn reduced its blood concentration, resulting in a marked reduction in its nephrotoxicity. On the other hand, TQ significantly attenuated the CA-produced reno-toxic effect, including a reduction in serum creatinine and cystatin C levels and improving kidney tubular and glomerular renal structures [23]. The TQ protective effect may refer to its antioxidant capacity. Hussein et al. also assessed the reno-protective effect of TQ (10 mg/kg b. wt./orally/day for 7 days) against CA (oral dose 25 mg/kg/b.wt./day)-mediated renal toxicity in rats. It was found to normalize increased levels of L-MDA in renal tissues and creatinine and urea in serum as well as the decreased catalase activity and GSH level. Moreover, it markedly upregulated Bcl-2 and downregulated PAI-1, NF-κB, p53, and caspase-3 gene expressions levels. Furthermore, TQ remarkably improved the renal damage and OS alterations via its anti-apoptosis, anti-inflammatory, and antioxidative properties [65].
Oleanolic acid is a triterpene pentacyclic carboxylic acid separated from Olea europaea that possesses hepato-protective, anticancer, and anti-inflammatory potential [24]. It presents a generalized protective effect against chronic cyclosporine nephropathy through Nrf2/HO-1 pathway upregulation resulting in increased levels of NQO-1, HO-1, GSH, SOD, GCL, and S-transferase via affecting the ARE gene, thereby decreasing apoptosis and degradation. This suggests that oleanolic acid could be a potential therapeutic agent for treating A-induced nephrotoxicity involving ARE/Nrf2/HO-1 [24].

2.6. Polysaccharides

Sulfated polysaccharides are a type of metabolite having ester-linked sulfate groups in their backbone. They are commonly reported in seaweeds and have various therapeutic applications [66,67]. They are glycosaminoglycans that can positively counteract glomerular disorders. It has been stated that they possessed an antioxidant potential and have a remarkable mitochondrial influence via their enhanced antioxidant state, decreased accumulation of ROS, improved mitochondrial membrane potential and ATP status, and prohibited release of cytochromes [68,69,70].
Genus Sargassum seaweed is a rich pool for their bioactivities with remarkable biomedical and pharmaceutical uses [71]. Sargassum wightii-sulphated polysaccharides (SWSPs) possess hypolipidemic effects, thus reducing the risk of glomerular dysfunction-associated hyperlipidemia [72].
A study conducted by [69] revealed that SWSPs (5 mg/kg/b.w., SC., for 21 days) possess a protective potential against CA-mediated nephrotoxicity (orally 25 mg/kg/b.w.), as indicated by improved body weight, normalized lysosomal enzymes and creatinine clearance, and attenuated morphological alterations in renal tissues caused by CA in rats [69]. Another study conducted by the same authors demonstrated that SWSPs modulate CA-induced mitochondrial dysfunction and tubular injuries via its powerful antioxidant effect, notably prohibiting mitochondrial oxidative stress through scavenging free radicals, boosting GPx and SOD, and improving the GSH levels. It also suppresses LPO and mitochondrial swelling [68].

3. Herbal Extracts Prevent CA-Induced Nephrotoxicity

Natural products, especially herbal extracts, have a marked role in folk medicine as protecting the kidneys due to their significant antioxidant and anti-inflammatory effects. Recently, several in vitro and in vivo models were implemented to discover the kidney-protective components of plants [1].

3.1. Zingiber officinale

Zingiber officinale, commonly named ginger, is a perennial plant that belongs to the Zingiberaceae family. The rhizome of the plant has a wide range of medical applications in the treatment of motion sickness, inflammation, and cancer [73]. The activity of ginger rhizomes could be attributed to their polyphenol contents that may be responsible for the antidiabetic, cardio-protective, and hepato-protective activities of the plant [74,75]. In addition, the polyphenol-rich extract (prepared using 80% acetone) could attenuate CA-induced disturbances in kidney function. The prepared extract reversed all alterations produced in the kidneys by CA through a significant improvement in the plasma and urine levels of creatinine, urea, Na+ and K+ electrolyte balance, as well as creatinine clearance. Moreover, it improved feeding patterns, relative kidney weight, and oxidative stress (GSH and SOD). These improvements were also confirmed by a histopathological study [76].

3.2. Phoenix dactylifera

The fruits of Phoenix dactylifera or date palm are widely used as food in many Middle-Eastern countries. Date pits, a byproduct of date palm, were found to be rich in polyphenolic compounds and exert antioxidant, antibacterial, and chemoprotective activities [77]. The protective effect of date pit aqueous extract (DPE) on CA-induced nephrotoxicity was studied. DPE enhanced kidney function after CA administration and increased glutathione levels. A marked decrease in LPO and increase in CAT levels were observed. These results were further confirmed through histopathological investigations of kidney tissues. It was proposed that DPE restored kidney functions in CA-induced nephrotoxicity in rats through antioxidant mechanisms [77].

3.3. Spinacea oleracea

Spinacea oleracea (spinach) is a green, leafy plant used as a food in many countries all over the world. It possesses antioxidant properties, and inhibits lipid peroxidation and hepatoprotective effects in CCl4-induced liver toxicity [78]. N-Hexane extract from spinach leaves was administered with CA for 14 days, and the results of the histopathological investigation of kidney tissues were compared to both CA and spinach-only groups. CA-treated groups presented marked kidney toxicity through vacuolation, necrosis, and loss of brush border in tubular cells. The co-administration of spinach with CA revealed a significant amelioration of all these histopathological lesions, suggesting that spinach hexane extract has a protective effect on CA-induced nephrotoxicity [78].

3.4. Ginseng

Ginseng is widely used in many countries due to its well-known biological activities. The antioxidant activity of ginseng constituents has been discussed and documented in many reports. The protective effect of Korean red ginseng extract (KRG) on CA-induced nephrotoxicity in a mouse model was investigated by measuring renal function, inflammatory mediators, and tubular fibrosis and apoptosis [79]. In addition, the effect of KRG on CA-treated proximal tubular cells (HK-2) was investigated in vitro. 8-Hydroxy-2′-deoxyguanosine (8-OhdG) in urine and tissues was used as a measure of oxidative stress. KRG treatment decreased creatinine levels and proinflammatory mediators, such as NO synthase and cytokines. Induced cellular apoptosis was also decreased by KRG treatment. Moreover, 8-OhdG levels were markedly decreased in urine and tissue samples following KRG administration (Table 3). It was concluded that KRG exerts its nephro-protective effect through antioxidant activity and the prevention of apoptosis [79].

3.5. Grape and Garlic

Black grapes and garlic are well-known antioxidant foods due to their allicin, alline, and resveratrol contents, respectively. The protective effect of dried black grapes and garlic aqueous extracts on CA-induced nephrotoxicity was investigated in rats by Durak et al. [81]. The grapes and garlic extract were given three days before CA administration for 10 days, and oxidative stress parameters in addition to histopathological investigations were performed. The administration of both plants reduced MDA levels in kidney tissues through the prevention of oxidative stress. Moreover, in a different study, the ingestion of 25 g/kg of dried black grapes with CA by rats significantly decreased MDA levels in the kidney tissues of rats. However, no significant difference was observed in SOD and catalase levels [91]. In the same context, Hussein et al. studied the protective effect of grape seed proanthocyanidin-rich extract (GSPE) on CA-induced nephrotoxicity. GPSE was standardized to contain 66.7 mg/g of total phenolics with an oligomeric proanthocyanidin ratio of 95%. GSPE extracts (200 mg/kg) was administered 7 days before and 21 during CA administration in rats [92]. GSPE treatment decreased serum creatinine, urea, and tissue MDA levels, and reduced glutathione levels. In addition, GSPE treatment retained Bcl-2, NF-κB, caspase-3, and P53 to their normal levels. Thus, grape seed extracts exerted their effect through antioxidant and anti-inflammatory properties, and the inhibition of apoptosis. Similar to other studies, GPSE ameliorated impaired kidney function upon co-administration with CA through its antioxidant properties and inhibition of apoptosis. In addition, GPSE did not affect CA plasma levels after administration [93].
Aged garlic extract (AGE) is an odorless material produced by the extraction of garlic for a long period of time (20 months) [93]. AGE was proved to be the most potent antioxidant among all garlic preparations. AGE in 0.25, 0.5, 1, and 2 g/kg was administered 3 days prior to CA treatment, followed by 10 days of co-administration. AGE in doses of 0.5–2 g/kg decreased renal creatinine and increased creatinine clearance, and ameliorated histopathological changes, such as vacuolation and tubular necrosis [94].

3.6. Green Tea

Tea is the most commonly consumed beverage worldwide, with a known abundance of polyphenol contents. The most abundant compounds in green tea are EGCG and catechin, which are known for their well-reported antioxidant activities. Green tea extract (GTE) with a concentration of 3% W/V was orally administered 21 days before CA and administered for 21 days with CA followed by 21 days alone. GTE was found to alleviate all kidney toxicity parameters, such as increasing GSH and catalase levels and decreasing MDA, creatinine, and urea levels. In addition, it ameliorated the lipid profile and serum glucose, LDH, and GGT levels affected by CA administration [82]. In another study by Mohamadin et al. [83], a 0.5, 1, and 1.5 % W/V solution prepared from instant lyophilized green tea powder was consumed by rats in the experiment 4 days before CA and concurrent with it for 21 days. In addition to the usual enhancement of kidney function and oxidative parameters, GTE inhibited the activity of lysosomal enzymes NAG, β-GU, and AP [83].

3.7. Ipomoea batatas

An aqueous leaf extract of Ipomoea batatas was orally administered in 200 and 400 mg/kg in rats concurrently with CA. It alleviated the CA-induced increase in serum inflammatory cytokines and kidney functions. Moreover, it retained the normal ionic sodium and potassium levels compared to the CA group, in addition to enhancing the impaired histopathological status of kidney tissues by CA [88].

3.8. Schisandra chinensis

In China, patients treated with CA are advised to consume pharmaceutical preparations containing Schisandra chinensis for protection from its side effects [95]. The plant is reported to contain several triterpenoids, such as schisandrol A, schisantherin A, schizandrin A, and schizandrin B. The administration of Schisandara extract (SCE) alleviated hepatorenal injuries induced by CA through the activation of the Nrf2 pathway and the inhibition of apoptosis [90].

3.9. Nigella sativa

Black seed (Nigella sativa) is widely used for culinary and medicinal purposes. Several reports confirmed the protective effects of Nigella sativa extract and its main constituent, thymoquinone, on cisplatin-induced nephrotoxicity [96,97]. Nigella sativa oil (NSO) in a dose of 2 mL/kg was co-administered with CA to rats, and their kidney function and oxidative stress parameters were investigated. NSO significantly improved renal functions as deduced from lowering serum creatinine and urea levels. In addition, oxidative parameters were markedly improved, such as tissue MDA, CAT, glutathione, and SOD levels. Moreover, the biochemical effects of NSO were confirmed further through the histopathological improvement of kidney tissues. Therefore, NSO ameliorated CA-induced nephrotoxicity through its possible antioxidant effect.

3.10. Cordyceps sinensis

C. sinensis is a plant widely used in Chinese folk medicine as a kidney tonic. The effect of the plant’s administration on the protection of kidneys from the toxic effects of CA in patients with transplantations was studied. The concurrent administration of C. sinensis and CA resulted in significantly reduced nephrotoxicity compared to the CA group of patients, as indicated by decreased serum creatinine, urea, and NAG levels. Moreover, CA plasma levels were the same in both groups [86].

3.11. Doum, Carob, and Fennel

Doum, carob, and fennel are edible plants widely used in Egypt for their culinary and medicinal properties. Fennel (Foeniculum vulgare) is widely cultivated in the Mediterranean region and used for its aroma and flavor in salad and many dishes, and for its antioxidant, antispasmodic, and antiflatulence properties in folk medicine [98]. Carob (Ceratonia siliqua), which belongs to the Fabaceae family, is widely used in the Mediterranean region as a beverage and food due to its carbohydrate, fiber, and phenolic contents [99]. Doum (Hyphaene thebaica) is a desert palm native to Egypt, Africa, and India. Its fruit pulp is widely used due to its minerals, phenolics, and linoleic acid content [100]. A recent study focused on its possible antihypertensive effects [101]. After the initial injection of rats with CA for 7 days, hey were allowed to consume food containing the three plants. The use of fennel, doum, and carob decreased serum creatinine levels; urinary levels of β2 microglobulin; and serum levels of ammonia, TGF-β1, and TNF-α; and decreased creatinine clearance. Furthermore, a histopathological assessment confirmed the protective effects of these plants through their possible anti-inflammatory effects [87].

4. Miscellaneous Natural Products

4.1. Propolis

Propolis is a bee product rich in a variety of natural constituents, mainly phenolics. Propolis gained popularity as an antioxidant and food additive that is used for treating several diseases. The 60% hydroalcoholic extract of propolis was studied for its nephro-protective effect against CA-induced kidney dysfunction in rats. Propolis extract was administered with CA in a dose of 100 mg/kg orally. It was found that serum cortisol, AST, ALT, and urea levels were markedly decreased upon propolis administration. Moreover, propolis decreased kidney and liver MDA levels, and increased catalase and reduced GSH levels [84].

4.2. Spirulina

Spirulina (Arthrospira platensis) is a filamentous blue–green microalgae that acquired its name from its spiral-shaped filaments. It contains carbohydrates, proteins, vitamin B, minerals, and carotenoids, such as beta carotene. It has antioxidant, anti-inflammatory, and nephro- and radioprotective activities. Spirulina at 1 g/kg was administered 15 days before irradiation or 5 days before and 10 days with CA. Gamma radiation and CA induced a marked elevation in serum creatinine, urea, lipids, and glucose levels, which was reversed by spirulina intake. In addition, spirulina increased kidney SOD and decreased MDA and nitrile levels. Biochemical parameters were confirmed further through histopathological studies. Moreover, kidney caspase-3 levels in the CA-treated group were significantly decreased by using spirulina [85].

5. Diet Prevents CA-Induced Nephrotoxicity

Less research has been conducted to assess the effect of dietary regimen on CA-induced reno-toxicity. We presented the results of these studies in the present paper.
Fish oil-derived omega-3 fatty acids have a protective potential against various metabolic disorders and diseases, such as MetS, cancer, neuro-degenerative and autoimmune disorders, diabetes, and CVD [102]. They play a significant role in anti-inflammatory processes and improve the antioxidant defense system [103]. Priyamvada et al. reported that dietary fish oil (DFO) alleviated gentamicin-produced oxidative damage and metabolic alterations because of its intrinsic antioxidant/biochemical properties [104,105]. In 2014, Hussein et al. demonstrated that CA remarkably increased the renal function tests, serum glucose, lipid profiles, haptoglobin, and serum (GGT and LDH) enzymes with a considerable lowering of serum albumin, electrolytes, and total protein. Co-treatment with DFO and CA remarkably reduced these parameters as compared with the CA-received group. Moreover, CA induced a considerable increase in MDA, along with a noticeable reduction in enzymatic and non-enzymatic antioxidants, TOC, and NO levels in the rat kidneys. Meanwhile, DFO improved renal function through a significant increase in the antioxidant status and decrease in peroxidative levels. These results reveal the usefulness and reno-protective capacity of DFO as a rich source of antioxidants in modulating CA-induced nephrotoxicity [40]. Moreover, it was reported that the antioxidant nutrients, such as vitamins C and E, ameliorate the toxic effects produced CA in kidneys, whereas vitamin E prohibits ROS and TX synthesis as well as lipid peroxidation caused by CA. Furthermore, they can improve renal function and CA-produced histological damage [106]. A study by Klawitter et al. in 2012 demonstrated that low-salt-diet-fed rats are more sensitive to CA (10 mg/kg/day CA for 28 days on low-salt diet) renal injuries than normal-salt-diet-fed rats (10 mg/kg/day CA for 28 days on low-salt diet). Their results show that micro- and macro-vesicular tubular epithelial vacuolizations and a reduced energy charge are more prominent in low-salt-fed rats. CA increased phospho-JAK2 and -STAT3 levels and reduced p65 and phospho-IKKγ proteins, leading to NF-κB signaling activation. Moreover, reduced lactate transport regulator CD147 and phospho-AKT expression were noted after the exposure of low-salt-fed rats to CA, revealing a decrease in glycolysis. Collectively, AKT, CD147, and JAK/STAT signaling displayed a remarkable role in CA reno-toxicity [107].
A protein-rich diet’s potential for several drugs producing renal toxicity was investigated. Protein feeding was reported to increase GFR and RPF levels in rats [108]. Therefore, it may counteract the vasoconstriction produced by CA and reduce its nephrotoxicity. A study performed by Pons et al. in 2003 demonstrated the protective effect of a casein-rich diet against in proximal tubule damage induced by CA. In CA (25 mg/kg/24h, I.P. for 7 days)-challenge rats, there were no significant differences in caloric consumption, bodyweight, urine output, and water intake among standard Rat Chow and high-protein fed (casein-rich diet for 2 weeks before CA) animals. However, β-GAL and NAG urine excretion and renal post-necrotic cellular regeneration were remarkably lower for the high-protein diet CA-treated rats than in those fed with standard Rat Chow, and no gold particle was observed over proximal tubule lysosomes in rich-protein-diet-fed rats [109]. Venkateswarlu et al. evaluated the LOBUN probiotic formulation’s (500 mg/kg/b.w. for twice or thrice a day from the 15th to 28th day) nephro-protective effect on CA (20 mg/kg SC, 15 days)-induced renal impairment in Wistar rats. In this study, CA-induced renal toxicity was indicated by increased BUN, serum creatinine, uric acid, and total protein levels, as well as urine potassium, proteins, and sodium. LOBUN (500 mg/kg b.w. thrice a day) provided appreciable reno-protection and alleviated the CKD symptoms against CA that was evidenced by biochemical and histological findings [80].
Olive oil is regarded as a superfood with numerous health benefits that are attributed to its unique contents, including high percent of MUFA (monounsaturated fatty acids) as well as other bioactive constituents. Its phenolics are reputed to have the potential as anti-inflammatory, antimicrobials, and antioxidants [110]. Elshama et al. investigated the protective potential of VOO (virgin olive oil, 1.25 mL/kg/day, GL) or naringenin (100 mg/kg/day, GL) co-administration on CA (25 mg/kg/day, GL)-induced renal damage in rats. The results reveal that VOO modulates CA-induced ultra-structure and morphologic changes, improves antioxidant status, and decreases urea and creatinine levels to the same extent as naringenin [28].

6. Natural Products’ Stability and Adverse Effects

The stability of herbal products as extracts or purified compounds represents an important issue in using natural products to combat ailments. The stability of herbal products includes its ability to preserve its identity, strength, and purity. However, during the process of extraction and preparation of natural products, the active constituents are subjected to oxidation, hydrolysis, microbial attack, and other environmental deterioration effects, which affect its stability [111]. The quality, effectiveness, and shelf life of natural medicines are all impacted by the presence and concentration of bioactive ingredients; therefore, monitoring their presence and concentration is crucial. The factors that may affect the stability of herbal products include: its presence in a complex mixture of different components, drug interaction, or decomposition during storage; physical and chemical stability; and finally the environmental factors. Different techniques could be used to overcome the instability of natural preparations, including nanoparticle coating to enhance shelf life, semisolid preparations based on supercritical carbon dioxide, liquid preparation coated with water-soluble cellulose, derivatives using polymeric plant-derived excipients in drug delivery, micro-encapsulation for active constituents, and adding antioxidants to prevent the oxidation of active compounds. A detailed discussion of the different methods for increasing stability have been previously published [111].
Many people think that pharmaceutical agents are too expensive and have unwanted side-effects; on the other hand, they believe that medicinal herbs must be efficient and safe. However, this prevalent faith that herbs are safe is shown to be faulty. Unfortunately, the contamination by mycotoxins, microbes, pesticides, and even heavy metals, such as arsenic, lead, or mercury, has been reported, especially among Internet-sold herbs [112]. Indeed, several studies reported the hepato-toxic potential of natural products. For example, black cohosh mediated liver injury through mitochondrial damage. EGCG (epigallocatechin gallate), the main phenolic in green tea, was reported to be the most potentially hepatotoxic constituent; in addition, green tea extract’s high doses may cause acute intensive liver injury. Additionally, several potentially dangerous interactions between herbs and drugs have been described [113]. Kava, valerian, St. John’s wort, and ginkgo, which are used for supporting mental health, interact with commonly utilized medications, e.g., the use of St. John’s wort with selective serotonin reuptake inhibitors could result in serotonin syndrome [114]. The CA’s bioavailability was found to be affected by many herbal extracts and traditional drugs that influence CA’s blood concentration. In a case report, St John’s wort and in vivo animal studies, liquorice, ginger, quercetin, and scutellariae radix were shown to decrease CA blood concentration. However, an increased CA concentration was noted with berberine, resveratrol, grapefruit juice, chamomile, or cannabidiol in animal studies [9]. On the other hand, it was stated that the concomitant use of Serenoa repens and Echinacea with CA should be avoided. Thus, the knowledge of a patient’s usage of natural products before CA administration is crucial to overcome the possible interactions between CA and herbal preparations.

7. Conclusions

Kidneys have an essential role in maintaining homeostasis. Kidney illnesses are serious health concerns that cause an economic burden and worrisome morbidity. They can occur following certain medications’ usage, such as CA that mediates its destructive effect through various cascades. Unfortunately, the pathogenesis of CA-induced reno-toxicity is complicated; its earlier diagnosis is difficult and effective treatment options are lacking. This has encouraged researchers to search for natural metabolites with fewer side effects. It was observed that several natural biomolecules have been reported to reduce or mitigate the severity of CA-induced renal toxicity (Figure 4).
These metabolites appear to have a crucial role in protecting and detoxifying renal tissues against CA-induced damage through their anti-apoptosis, anti-inflammatory, and antioxidative properties. The presented data in this work provided a scientific bases for the rational utilization development and discovery of phytoconstituents for treating practices. In this literature survey, it was observed that the reno-protection of the most-studied plants or their phytoconstituents was explained as related to oxidative stress. Meanwhile, there are other mechanisms of reno-protection that may be responsible for the protective effect on the kidneys, which need further study. Additionally, some studies revealed that dietary regimen has a marked effect on CA-induced reno-toxicity. Most of the reported studies were conducted on animal models. Understanding how natural products act through various signaling pathways will produce a better insight into the potential prevention and treatment of CA-induced renal toxicity. However, further clinical studies are warranted to amend the pharmacokinetic and pharmacodynamic understanding of these metabolites. Additionally, a further evaluation of other classes of natural metabolites reported by various sources is required.
List of abbreviations: 2-DG: 2-Deoxy-D-glucose; 8-iso-PGF2α: 8-epi-prostaglandin F2α; ALP: alkaline phosphatase; AP: acid phosphatase; 8-OHdG: 8-hydroxy-2′-deoxyguanosine; AREs: antioxidant-response elements; b.w.: body weight; BUN: blood urea nitrogen; CA: cyclosporine A; CAT: catalase; c-GT; c-Glutamyl transferase; CVD: cardiovascular disease; CKD: chronic kidney disease; CMC: carboxy methyl cellulose; Cr: creatinine; CYP3A: cytochrome P450, family 3, subfamily A; EGCG: epigallocatechin gallate; EMT: epithelial–mesenchymal transition; GCLM: glutamate-cysteine ligase-modifier subunit; GFR: glomerular filtration rate; GGT: gamma glutamyl transferase; GL: gastric lavage; GSH-Px: glutathione peroxidase; GR: glutathione reductase; GSH: reduced glutathione; GST: glutathione-S-transferase; HK-2: human proximal tubular epithelial cell line; HO-1: heme oxygenase-1; HSP-70: heat shock protein-70; I.P.: intra-peritoneal; iNOS: inducible nitric oxide synthase; LDH: lactate dehydrogenase; c-GT: c-Glutamyl transferase; LDL: low-density lipoprotein; LPO: lipid peroxidation; MMP-2: matrix metalloproteinase-2; MetS: metabolic syndrome; MUFAs: monounsaturated fatty acids; NAG: N-acetyl-β-d-glucosaminidase; NF-kB: nuclear factor kappa B; NO: nitric oxide; NPs: nanoparticles; NQO1 NAD(P) H: quinone oxidoreductase 1; Nrf2: nuclear factor erythroid 2-related factor 2; OHdG: 8-Hydroxy-2′-deoxyguanosine; OS: oxidative stress; p.o.: perorally; PC: plasma creatinine; PLs: phospholipids; PLGA: poly(lactic-co-glycolic) acid; Px: peroxidase; ROS: reactive oxygen species; RPF: renal plasma flow; SC: subcutaneously; SBP: systolic blood pressure; ScB: Schisandrin B; SWSPs: Sargassum wightii-sulphated polysaccharides; TAO: total antioxidant capacity; TBARS: thiobarbituric acid-reactive substances; TC: total cholesterol; TAGs: triacylglycerols; TP: total protein; TX: thromboxane; TGF-β1: transforming growth factor-β1; TQ: thymoquinone; UA: uric acid; VOO: virgin olive oil; XO: xanthine oxidase; β2MG: β2-microglobulin; β-GAL: β-galactosidase; ΔΨm: mitochondrial transmembrane potential.

Author Contributions

Conceptualization, S.R.M.I., H.M.A., A.M.E.-H., G.A.M. and R.S.E.-D.; methodology, S.R.M.I., H.M.A., A.M.E.-H., G.A.M. and R.S.E.-D.; software, A.A.A. (Ali A. Alqarni), W.A.S., A.A.A. (Aisha A. Alhaddad), A.T.R., K.F.G. and R.S.E.-D.; resources, A.A.A. (Ali A. Alqarni), W.A.S., A.A.A. (Aisha A. Alhaddad), A.T.R., R.S.E.-D. and K.F.G.; writing—original draft preparation, S.R.M.I., H.M.A., A.M.E.-H., G.A.M. and R.S.E.-D.; writing—review and editing, S.R.M.I., H.M.A., A.M.E.-H., G.A.M., A.A.A. (Ali A. Alqarni), W.A.S., A.A.A. (Aisha A. Alhaddad), A.T.R. and R.S.E.-D. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

2-DG: 2-Deoxy-D-glucose; 8-iso-PGF2α: 8-epi-prostaglandin F2α; ALP: alkaline phosphatase; AP: acid phosphatase; 8-OHdG: 8-hydroxy-2′-deoxyguanosine; AREs: antioxidant-response elements; b.w.: body weight; BUN: blood urea nitrogen; CA: cyclosporine A; CAT: catalase; c-GT; c-Glutamyl transferase; CVD: cardiovascular disease; CKD: chronic kidney disease; CMC: carboxy methyl cellulose; Cr: creatinine; CYP3A: cytochrome P450, family 3, subfamily A; EGCG: epigallocatechin gallate; EMT: epithelial–mesenchymal transition; GCLM: glutamate-cysteine ligase-modifier subunit; GFR: glomerular filtration rate; GGT: gamma glutamyl transferase; GL: gastric lavage; GSH-Px: glutathione peroxidase; GR: glutathione reductase; GSH: reduced glutathione; GST: glutathione-S-transferase; HK-2: human proximal tubular epithelial cell line; HO-1: heme oxygenase-1; HSP-70: heat shock protein-70; I.P.: intra-peritoneal; iNOS: inducible nitric oxide synthase; LDH: lactate dehydrogenase; c-GT: c-Glutamyl transferase; LDL: low-density lipoprotein; LPO: lipid peroxidation; MMP-2: matrix metalloproteinase-2; MetS: metabolic syndrome; MUFAs: monounsaturated fatty acids; NAG: N-acetyl-β-d-glucosaminidase; NF-kB: nuclear factor kappa B; NO: nitric oxide; NPs: nanoparticles; NQO1 NAD(P) H: quinone oxidoreductase 1; Nrf2: nuclear factor erythroid 2-related factor 2; OHdG: 8-Hydroxy-2′-deoxyguanosine; OS: oxidative stress; p.o.: perorally; PC: plasma creatinine; PLs: phospholipids; PLGA: poly(lactic-co-glycolic) acid; Px: peroxidase; ROS: reactive oxygen species; RPF: renal plasma flow; SC: subcutaneously; SBP: systolic blood pressure; ScB: Schisandrin B; SWSPs: Sargassum wightii-sulphated polysaccharides; TAO: total antioxidant capacity; TBARS: thiobarbituric acid-reactive substances; TC: total cholesterol; TAGs: triacylglycerols; TP: total protein; TX: thromboxane; TGF-β1: transforming growth factor-β1; TQ: thymoquinone; UA: uric acid; VOO: virgin olive oil; XO: xanthine oxidase; β2MG: β2-microglobulin; β-GAL: β-galactosidase; ΔΨm: mitochondrial transmembrane potential.

References

  1. Jivishov, E.; Nahar, L.; Sarker, S.D. Nephroprotective natural products. In Annual Reports in Medicinal Chemistry; Elsevier: Amsterdam, The Netherlands, 2020; Volume 55, pp. 251–271. [Google Scholar]
  2. Touiti, N.; Houssaini, T.S.; Achour, S. Overview on pharmacovigilance of nephrotoxic herbal medicines used worldwide. Clin. Phytoscience 2021, 7, 1–8. [Google Scholar] [CrossRef]
  3. Kolangi, F.; Memariani, Z.; Bozorgi, M.; Mozaffarpur, S.A.; Mirzapour, M. Herbs with potential nephrotoxic effects according to the traditional Persian medicine: Review and assessment of scientific evidence. Curr. Drug Metab. 2018, 19, 628–637. [Google Scholar] [CrossRef]
  4. Wu, H.; Huang, J. Drug-induced nephrotoxicity: Pathogenic mechanisms, biomarkers and prevention strategies. Curr. Drug Metab. 2018, 19, 559–567. [Google Scholar] [CrossRef]
  5. Faria, J.; Ahmed, S.; Gerritsen, K.G.; Mihaila, S.M.; Masereeuw, R. Kidney-based in vitro models for drug-induced toxicity testing. Arch. Toxicol. 2019, 93, 3397–3418. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Kim, S.Y.; Moon, A. Drug-induced nephrotoxicity and its biomarkers. Biomol. Ther. 2012, 20, 268–272. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Mostafavi-Pour, Z.; Khademi, F.; Zal, F.; Sardarian, A.R.; Amini, F. In vitro analysis of CsA-induced hepatotoxicity in HepG2 cell line: Oxidative stress and α2 and β1 integrin subunits expression. Hepat. Mon. 2013, 13, e11447. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Ciresi, D.L.; Lloyd, M.A.; Sandberg, S.M.; Heublein, D.M.; Edwards, B.S. The sodium retaining effects of cyclosporine. Kidney Int. 1992, 41, 1599–1605. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Colombo, D.; Lunardon, L.; Bellia, G. Cyclosporine and herbal supplement interactions. J. Toxicol. 2014, 2014, 145325. [Google Scholar] [CrossRef]
  10. Colombo, M.D.; Perego, R.; Bellia, G. Drug interaction and potential side effects of cyclosporine. Adv. Exp. Med. Biol. 2013, 74, 1–24. [Google Scholar]
  11. Wu, Q.; Wang, X.; Nepovimova, E.; Wang, Y.; Yang, H.; Kuca, K. Mechanism of cyclosporine A nephrotoxicity: Oxidative stress, autophagy, and signalings. Food Chem. Toxicol. 2018, 118, 889–907. [Google Scholar] [CrossRef]
  12. Tedesco, D.; Haragsim, L. Cyclosporine: A Review. J. Transplant. 2012, 2012, 230386. [Google Scholar] [CrossRef] [PubMed]
  13. Lai, Q.; Luo, Z.; Wu, C.; Lai, S.; Wei, H.; Li, T.; Wang, Q.; Yu, Y. Attenuation of cyclosporine A induced nephrotoxicity by schisandrin B through suppression of oxidative stress, apoptosis and autophagy. Int. Immunopharmacol. 2017, 52, 15–23. [Google Scholar] [CrossRef] [PubMed]
  14. Damiano, S.; Ciarcia, R.; Montagnaro, S.; Pagnini, U.; Garofano, T.; Capasso, G.; Florio, S.; Giordano, A. Prevention of nephrotoxicity induced by cyclosporine-A: Role of antioxidants. J. Cell. Biochem. 2015, 116, 364–369. [Google Scholar] [CrossRef] [PubMed]
  15. Ciarcia, R.; Damiano, S.; Florio, A.; Spagnuolo, M.; Zacchia, E.; Squillacioti, C.; Mirabella, N.; Florio, S.; Pagnini, U.; Garofano, T. The protective effect of apocynin on cyclosporine A-induced hypertension and nephrotoxicity in rats. J. Cell. Biochem. 2015, 116, 1848–1856. [Google Scholar] [CrossRef] [PubMed]
  16. Hamon, J.; Jennings, P.; Bois, F.Y. Systems biology modeling of omics data: Effect of cyclosporine a on the Nrf2 pathway in human renal cells. BMC Syst. Biol. 2014, 8, 76. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Liu, Q.-f.; Ye, J.-m.; Yu, L.-x.; Dong, X.-h.; Feng, J.-h.; Xiong, Y.; Gu, X.-x.; Li, S.-s. Klotho mitigates cyclosporine A (CsA)-induced epithelial–mesenchymal transition (EMT) and renal fibrosis in rats. Int. Urol. Nephrol. 2017, 49, 345–352. [Google Scholar] [CrossRef]
  18. McMorrow, T.; Gaffney, M.M.; Slattery, C.; Campbell, E.; Ryan, M.P. Cyclosporine A induced epithelial–mesenchymal transition in human renal proximal tubular epithelial cells. Nephrol. Dial. Transplant. 2005, 20, 2215–2225. [Google Scholar] [CrossRef] [Green Version]
  19. Kim, H.S.; Choi, S.-I.; Jeung, E.-B.; Yoo, Y.-M. Cyclosporine A induces apoptotic and autophagic cell death in rat pituitary GH3 cells. PLoS ONE 2014, 9, e108981. [Google Scholar] [CrossRef]
  20. Shi, S.-H.; Zheng, S.-S.; Jia, C.-K.; Zhu, Y.-F.; Xie, H.-Y. Inhibitory effect of tea polyphenols on transforming growth factor-beta1 expression in rat with cyclosporine A-induced chronic nephrotoxicity. Acta Pharmacol. Sin. 2004, 25, 98–103. [Google Scholar]
  21. Wirestam, L.; Frodlund, M.; Enocsson, H.; Skogh, T.; Wetterö, J.; Sjöwall, C. Osteopontin is associated with disease severity and antiphospholipid syndrome in well characterised Swedish cases of SLE. Lupus Sci. Med. 2017, 4, e000225. [Google Scholar] [CrossRef] [Green Version]
  22. Anjaneyulu, M.; Tirkey, N.; Chopra, K. Attenuation of cyclosporine-induced renal dysfunction by catechin: Possible antioxidant mechanism. Ren. Fail. 2003, 25, 691–707. [Google Scholar] [CrossRef] [PubMed]
  23. Alrashedi, M.G.; Ali, A.S.; Ali, S.S.; Khan, L.M. Impact of thymoquinone on cyclosporine A pharmacokinetics and toxicity in rodents. J. Pharm. Pharmacol. 2018, 70, 1332–1339. [Google Scholar] [CrossRef] [PubMed]
  24. Hong, Y.A.; Lim, J.H.; Kim, M.Y.; Kim, E.N.; Koh, E.S.; Shin, S.J.; Choi, B.S.; Park, C.W.; Chang, Y.S.; Chung, S. Delayed treatment with oleanolic acid attenuates tubulointerstitial fibrosis in chronic cyclosporine nephropathy through Nrf2/HO-1 signaling. J. Transl. Med. 2014, 12, 1–10. [Google Scholar] [CrossRef] [Green Version]
  25. Lai, Q.; Wei, J.; Mahmoodurrahman, M.; Zhang, C.; Quan, S.; Li, T.; Yu, Y. Pharmacokinetic and nephroprotective benefits of using Schisandra chinensis extracts in a cyclosporine A-based immune-suppressive regime. Drug Des. Dev. Ther. 2015, 9, 4997–5018. [Google Scholar]
  26. Gado, A.M.; Adam, A.N.I.; Aldahmash, B.A. Protective effect of lycopene against nephrotoxicity induced by cyclosporine in rats. Life Sci. J. 2013, 10, 1850–1856. [Google Scholar]
  27. Magendiramani, V.; Umesalma, S.; Kalayarasan, S.; Nagendraprabhu, P.; Arunkumar, J.; Sudhandiran, G. S-allylcysteine attenuates renal injury by altering the expressions of iNOS and matrix metallo proteinase-2 during cyclosporine-induced nephrotoxicity in Wistar rats. J. Appl. Toxicol. 2009, 29, 522–530. [Google Scholar] [CrossRef] [PubMed]
  28. Said Elshama, S.; Osman, H.-E.H.; El-Kenawy, A.E.-M. Renoprotective effects of naringenin and olive oil against cyclosporine-induced nephrotoxicity in rats. Iranian J. Toxicol. 2016, 10, 27–37. [Google Scholar] [CrossRef] [Green Version]
  29. Chandramohan, Y.; Parameswari, C.S. Therapeutic efficacy of naringin on cyclosporine (A) induced nephrotoxicity in rats: Involvement of hemeoxygenase-1. Pharmacol. Rep. 2013, 65, 1336–1344. [Google Scholar] [CrossRef] [Green Version]
  30. Fan, F.-Y.; Sang, L.-X.; Jiang, M. Catechins and their therapeutic benefits to inflammatory bowel disease. Molecules 2017, 22, 484. [Google Scholar] [CrossRef] [Green Version]
  31. Almatroodi, S.A.; Almatroudi, A.; Khan, A.A.; Alhumaydhi, F.A.; Alsahli, M.A.; Rahmani, A.H. Potential therapeutic targets of epigallocatechin gallate (EGCG), the most abundant catechin in green tea, and its role in the therapy of various types of cancer. Molecules 2020, 25, 3146. [Google Scholar] [CrossRef]
  32. Bai, Z.-L.; Tay, V.; Guo, S.-Z.; Ren, J.; Shu, M.-G. Silibinin induced human glioblastoma cell apoptosis concomitant with autophagy through simultaneous inhibition of mTOR and YAP. BioMed Res. Int. 2018, 2018, 6165192. [Google Scholar] [CrossRef] [PubMed]
  33. Fattah, E.A.; Hashem, H.E.; Ahmed, F.A.; Ghallab, M.A.; Varga, I.; Polak, S. Prophylactic role of curcumin against cyclosporine-induced nephrotoxicity: Histological and immunohistological study. Gen. Physiol. Biophys. 2010, 29, 85–94. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. BenSaad, L.A.; Kim, K.H.; Quah, C.C.; Kim, W.R.; Shahimi, M. Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum. BMC Complement. Altern. Med. 2017, 17, 47. [Google Scholar]
  35. Abdul-Hamid, M.; Abdella, E.M.; Galaly, S.R.; Ahmed, R.H. Protective effect of ellagic acid against cyclosporine A-induced histopathological, ultrastructural changes, oxidative stress, and cytogenotoxicity in albino rats. Ultrastruct. Pathol. 2016, 40, 205–221. [Google Scholar] [CrossRef] [PubMed]
  36. Gökçe, A.; Oktar, S.; Yönden, Z.; Aydın, M.; İlhan, S.; Özkan, O.V.; Davarcı, M.; Yalçınkaya, F.R. Protective effect of caffeic acid phenethyl ester on cyclosporine A-induced nephrotoxicity in rats. Ren. Fail. 2009, 31, 843–847. [Google Scholar] [CrossRef]
  37. Chander, V.; Tirkey, N.; Chopra, K. Resveratrol, a polyphenolic phytoalexin protects against cyclosporine-induced nephrotoxicity through nitric oxide dependent mechanism. Toxicology 2005, 210, 55–64. [Google Scholar] [CrossRef] [PubMed]
  38. Italia, J.; Datta, P.; Ankola, D.; Kumar, M. Nanoparticles enhance per oral bioavailability of poorly available molecules: Epigallocatechin gallate nanoparticles ameliorates cyclosporine induced nephrotoxicity in rats at three times lower dose than oral solution. J. Biomed. Nanotechnol. 2008, 4, 304–312. [Google Scholar] [CrossRef]
  39. Mun, K. Effect of epigallocatechin gallate on renal function in cyclosporine-induced nephrotoxicity. Transplant. Proc. 2004, 36, 2133–2134. [Google Scholar] [CrossRef]
  40. Hussein, S.A.; Ragab, O.A.; El-Eshmawy, M.A. Renoprotective effect of dietary fish oil on cyclosporine A: Induced nephrotoxicity in rats. Asian J. Biochem. 2014, 9, 71–85. [Google Scholar] [CrossRef] [Green Version]
  41. Zhu, S.; Wang, Y.; Chen, M.; Jin, J.; Qiu, Y.; Huang, M.; Huang, Z. Protective effect of schisandrin B against cyclosporine A-induced nephrotoxicity in vitro and in vivo. Am. J. Chin. Med. 2012, 40, 551–566. [Google Scholar] [CrossRef]
  42. Ateşşahin, A.; Çeribaşı, A.O.; Yılmaz, S. Lycopene, a carotenoid, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rats. Basic Clin. Pharmacol. Toxicol. 2007, 100, 372–376. [Google Scholar] [CrossRef] [PubMed]
  43. Aiman, A.-Q.; Nesrin, M.; Amal, A.; Said, A.-D. The possible Ameliorating and Antioxidant Effects of Curcumin against Cyclosporine-Induced renal Impairment in Rats Kidney. Bull. Environ. Pharmacol. Life Sci. 2020, 9, 87–93. [Google Scholar]
  44. Huang, J.; Yao, X.; Weng, G.; Qi, H.; Ye, X. Protective effect of curcumin against cyclosporine A-induced rat nephrotoxicity. Mol. Med. Rep. 2018, 17, 6038–6044. [Google Scholar] [CrossRef] [Green Version]
  45. Tirkey, N.; Pilkhwal, S.; Kuhad, A.; Chopra, K. Hesperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney. BMC Pharmacol. 2005, 5, 2. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Yüce, A.; Ateşşahin, A.; Çeribaşı, A.O. Amelioration of cyclosporine A-induced renal, hepatic and cardiac damages by ellagic acid in rats. Basic Clin. Pharmacol. Toxicol. 2008, 103, 186–191. [Google Scholar] [CrossRef] [PubMed]
  47. Zima, T.; Kamenikova, L.; Janebova, M.; Buchar, E.; Crkovska, J.; Tesar, V. The effect of silibinin on experimental cyclosporine nephrotoxicity. Ren. Fail. 1998, 20, 471–479. [Google Scholar] [CrossRef]
  48. Buffoli, B.; Pechánová, O.; Kojšová, S.; Andriantsitohaina, R.; Giugno, L.; Bianchi, R.; Rezzani, R. Provinol prevents CsA-induced nephrotoxicity by reducing reactive oxygen species, iNOS, and NF-kB expression. J. Histochem. Cytochem. 2005, 53, 1459–1468. [Google Scholar] [CrossRef] [Green Version]
  49. Rezzani, R.; Rodella, L.F.; Tengattini, S.; Bonomini, F.; Pechanova, O.; Kojšová, S.; Andriantsitohaina, R.; Bianchi, R. Protective role of polyphenols in cyclosporine A-induced nephrotoxicity during rat pregnancy. J. Histochem. Cytochem. 2006, 54, 923–932. [Google Scholar] [CrossRef]
  50. Rezzani, R.; Tengattini, S.; Bonomini, F.; Filippini, F.; Pechánová, O.; Bianchi, R.; Andriantsitohaina, R. Red wine polyphenols prevent cyclosporine-induced nephrotoxicity at the level of the intrinsic apoptotic pathway. Physiol. Res. 2009, 58, 511–519. [Google Scholar] [CrossRef]
  51. Khan, N.; Afaq, F.; Mukhtar, H. Cancer chemoprevention through dietary antioxidants: Progress and promise. Antioxid. Redox Signal. 2008, 10, 475–510. [Google Scholar] [CrossRef]
  52. Bingul, I.; Olgac, V.; Bekpinar, S.; Uysal, M. The protective effect of resveratrol against cyclosporine A-induced oxidative stress and hepatotoxicity. Arch. Physiol. Biochem. 2021, 127, 551–556. [Google Scholar] [CrossRef]
  53. Lee, J.-H.; Seo, Y.-S.; Lim, D.-Y. Provinol inhibits catecholamine secretion from the rat adrenal medulla. Korean J. Physiol. Pharmacol. 2009, 13, 229–239. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Pechanova, O.; Rezzani, R.; Babál, P.; Bernatova, I.; Andriantsitohaina, R. Beneficial effects of Provinols: Cardiovascular system and kidney. Physiol. Res. 2006, 55, S17–S30. [Google Scholar] [CrossRef] [PubMed]
  55. Shah, A.J.; Prasanth Kumar, S.; Rao, M.V.; Pandya, H.A. Ameliorative effects of curcumin towards cyclosporine-induced genotoxic potential: An in vitro and in silico study. Drug Chem. Toxicol. 2018, 41, 259–269. [Google Scholar] [CrossRef] [PubMed]
  56. Bunel, V.; Antoine, M.H.; Nortier, J.; Duez, P.; Stévigny, C. Protective effects of schizandrin and schizandrin B towards cisplatin nephrotoxicity in vitro. J. Appl. Toxicol. 2014, 34, 1311–1319. [Google Scholar] [CrossRef] [Green Version]
  57. Stacchiotti, A.; Volti, G.L.; Lavazza, A.; Schena, I.; Aleo, M.F.; Rodella, L.F.; Rezzani, R. Different role of Schisandrin B on mercury-induced renal damage in vivo and in vitro. Toxicology 2011, 286, 48–57. [Google Scholar] [CrossRef] [PubMed]
  58. Chiu, P.Y.; Leung, H.Y.; Ko, K.M. Schisandrin B enhances renal mitochondrial antioxidant status, functional and structural integrity, and protects against gentamicin-induced nephrotoxicity in rats. Biol. Pharm. Bull. 2008, 31, 602–605. [Google Scholar] [CrossRef] [Green Version]
  59. Amorim, A.G.; Souza, J.M.; Santos, R.C.; Gullon, B.; Oliveira, A.; Santos, L.F.; Virgino, A.L.; Mafud, A.C.; Petrilli, H.M.; Mascarenhas, Y.P. HPLC-DAD, ESI–MS/MS, and NMR of Lycopene Isolated From P. guajava L. and Its Biotechnological Applications. Eur. J. Lipid Sci. Technol. 2018, 120, 1700330. [Google Scholar] [CrossRef] [Green Version]
  60. Tapiero, H.; Townsend, D.M.; Tew, K.D. The role of carotenoids in the prevention of human pathologies. Biomed. Pharmacother. 2004, 58, 100–110. [Google Scholar] [CrossRef]
  61. Matos, H.R.; Di Mascio, P.; Medeiros, M.H. Protective effect of lycopene on lipid peroxidation and oxidative DNA damage in cell culture. Arch. Biochem. Biophys. 2000, 383, 56–59. [Google Scholar] [CrossRef]
  62. Karahan, İ.; Ateşşahin, A.; Yılmaz, S.; Çeribaşı, A.; Sakin, F. Protective effect of lycopene on gentamicin-induced oxidative stress and nephrotoxicity in rats. Toxicology 2005, 215, 198–204. [Google Scholar] [CrossRef] [PubMed]
  63. Avula, P.R.; Asdaq, S.M.; Asad, M. Effect of aged garlic extract and s-allyl cysteine and their interaction with atenolol during isoproterenol induced myocardial toxicity in rats. Indian J. Pharmacol. 2014, 46, 94–99. [Google Scholar] [PubMed] [Green Version]
  64. Farag, M.M.; Ahmed, G.O.; Shehata, R.R.; Kazem, A.H. Thymoquinone improves the kidney and liver changes induced by chronic cyclosporine A treatment and acute renal ischaemia/reperfusion in rats. J. Pharm. Pharmacol. 2015, 67, 731–739. [Google Scholar] [CrossRef] [PubMed]
  65. Hussein, S.A.; Elsenosi, Y.; Esmael, T.E.A.; Amin, A.; Sarhan, E.A.M. Thymoquinone suppressed Cyclosporine A-induced Nephrotoxicity in rats via antioxidant activation and inhibition of inflammatory and apoptotic signaling pathway. Benha Vet. Med. J. 2020, 39, 40–46. [Google Scholar]
  66. Zaporozhets, T.; Besednova, N. Prospects for the therapeutic application of sulfated polysaccharides of brown algae in diseases of the cardiovascular system. Pharm. Biol. 2016, 54, 3126–3135. [Google Scholar] [CrossRef]
  67. Patel, S. Therapeutic importance of sulfated polysaccharides from seaweeds: Updating the recent findings. 3 Biotech 2012, 2, 171–185. [Google Scholar] [CrossRef] [Green Version]
  68. Josephine, A.; Amudha, G.; Veena, C.K.; Preetha, S.P.; Rajeswari, A.; Varalakshmi, P. Beneficial effects of sulfated polysaccharides from Sargassum wightii against mitochondrial alterations induced by Cyclosporine A in rat kidney. Mol. Nutr. Food Res. 2007, 51, 1413–1422. [Google Scholar] [CrossRef]
  69. Josephine, A.; Veena, C.K.; Amudha, G.; Preetha, S.P.; Sundarapandian, R.; Varalakshmi, P. Sulphated Polysaccharides: New Insight in the Prevention of Cyclosporine A-Induced Glomerular Injury. Basic Clin. Pharmacol. Toxicol. 2007, 101, 9–15. [Google Scholar] [CrossRef]
  70. Miao, B.; Li, J.; Fu, X.; Gan, L.; Xin, X.; Geng, M. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits T cell apoptosis by combating oxidative damage of mitochondria. Mol. Pharmacol. 2005, 68, 1716–1727. [Google Scholar] [CrossRef] [Green Version]
  71. Maneesh, A.; Chakraborty, K.; Makkar, F. Pharmacological activities of brown seaweed Sargassum wightii (Family Sargassaceae) using different in vitro models. Int. J. Food Prop. 2017, 20, 931–945. [Google Scholar] [CrossRef] [Green Version]
  72. Josephine, A.; Veena, C.K.; Amudha, G.; Preetha, S.P.; Varalakshmi, P. Protective role of sulphated polysaccharides in abating the hyperlipidemic nephropathy provoked by cyclosporine A. Arch. Toxicol. 2007, 81, 371–379. [Google Scholar] [CrossRef] [PubMed]
  73. Ernst, E.; Pittler, M. Efficacy of ginger for nausea and vomiting: A systematic review of randomized clinical trials. Br. J. Anaesth. 2000, 84, 367–371. [Google Scholar] [CrossRef] [PubMed]
  74. Kazeem, M.I.; Akanji, M.A.; Yakubu, M.T.; Ashafa, A.O.T. Protective effect of free and bound polyphenol extracts from ginger (Zingiber officinale Roscoe) on the hepatic antioxidant and some carbohydrate metabolizing enzymes of streptozotocin-induced diabetic rats. Evid.-Based Complement. Altern. Med. 2013, 2013, 935486. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Laight, D.; Carrier, M.; Änggård, E. Antioxidants, diabetes and endothelial dysfunction. CardiovaSC Res. 2000, 47, 457–464. [Google Scholar] [CrossRef] [Green Version]
  76. Adekunle, I.A.; Imafidon, C.E.; Oladele, A.A.; Ayoka, A.O. Ginger polyphenols attenuate cyclosporine-induced disturbances in kidney function: Potential application in adjuvant transplant therapy. Pathophysiology 2018, 25, 101–115. [Google Scholar] [CrossRef]
  77. Abduljawad, E.A. Potential Antioxidant Effect of Date Pits Extract on Nephrotoxicity induced by Cyclosporine-A in Male Rats. Int. J. Pharm. Phytopharmacol. Res. 2019, 9, 21–27. [Google Scholar]
  78. Lone, K.P. Protective Effect of Sponacea Oleracea Extract on cyclosporine-A induced nephrotoxixicty in male albino rats. Biomedica 2016, 32, 935486. [Google Scholar]
  79. Doh, K.C.; Lim, S.W.; Piao, S.G.; Jin, L.; Heo, S.B.; Zheng, Y.F.; Bae, S.K.; Hwang, G.H.; Min, K.I.; Chung, B.H. Ginseng treatment attenuates chronic cyclosporine nephropathy via reducing oxidative stress in an experimental mouse model. Am. J. Nephrol. 2013, 37, 421–433. [Google Scholar] [CrossRef]
  80. Venkateswarlu, K.; Heerasingh, T.; Babu, C.N.; Triveni, S.; Manasa, S.; Babu, T.N.B. Preclinical evaluation of nephroprotective potential of a probiotic formulation LOBUN on Cyclosporine-A induced renal dysfunction in Wistar rats. Braz. J. Pharm. Sci. 2017, 53, e16042. [Google Scholar] [CrossRef]
  81. Durak, I.; Çetin, R.; Çandır, Ö.; Devrim, E.; Kılıçoğlu, B.; Avcı, A. Black grape and garlic extracts protect against cyclosporine a nephrotoxicity. Immunol. Investig. 2007, 36, 105–114. [Google Scholar] [CrossRef]
  82. Hussein, S.A.; Ragab, O.A.; El-Eshmawy, M.A. Protective effect of green tea extract on cyclosporine A: Induced nephrotoxicity in rats. J. Biol. Sci. 2014, 14, 248–257. [Google Scholar] [CrossRef]
  83. Mohamadin, A.; El-Beshbishy, H.; El-Mahdy, M. Green tea extract attenuates cyclosporine A-induced oxidative stress in rats. Pharmacol. Res. 2005, 51, 51–57. [Google Scholar] [CrossRef] [PubMed]
  84. Seven, I.; Baykalir, B.G.; Seven, P.T.; Dağoğlu, G. The ameliorative effects of propolis against cyclosporine A induced hepatotoxicity and nephrotoxicity in rats. System 2014, 10, 15. [Google Scholar]
  85. Aziz, M.M.; Eid, N.I.; Nada, A.S.; Amin, N.E.-D.; Ain-Shoka, A.A. Possible protective effect of the algae spirulina against nephrotoxicity induced by cyclosporine A and/or gamma radiation in rats. Environ. Sci. Pollut. Res. 2018, 25, 9060–9070. [Google Scholar] [CrossRef]
  86. Xu, F.; Huang, J.; Jiang, L.; Xu, J.; Mi, J. Amelioration of cyclosporin nephrotoxicity by Cordyceps sinensis in kidney-transplanted recipients. Nephrol. Dial. Transplant. 1995, 10, 142–143. [Google Scholar]
  87. Shalby, A.; Hamza, A.; Ahmed, H. New insight on the anti-inflammatory effect of some Egyptian plants against renal dysfunction induced by cyclosporine. Eur. Rev. Med. Pharmacol. Sci. 2012, 16, 455–461. [Google Scholar]
  88. Shatwan, I.M. Renoprotective Effect Of Ipomoea Batatas Aqueous Leaf Extract On Cyclosporine-Induced Renal Toxicity In Male Rats. Pharmacophores 2019, 10, 85–92. [Google Scholar]
  89. Uz, E.; Bayrak, O.; Uz, E.; Kaya, A.; Bayrak, R.; Uz, B.; Turgut, F.H.; Bavbek, N.; Kanbay, M.; Akcay, A. Nigella sativa oil for prevention of chronic cyclosporine nephrotoxicity: An experimental model. Am. J. Nephrol. 2008, 28, 517–522. [Google Scholar] [CrossRef]
  90. Wei, Y.; Luo, Z.; Zhou, K.; Wu, Q.; Xiao, W.; Yu, Y.; Li, T. Schisandrae chinensis fructus extract protects against hepatorenal toxicity and changes metabolic ions in cyclosporine A rats. Nat. Prod. Res. 2019, 35, 2915–2920. [Google Scholar] [CrossRef]
  91. Ergüder, İ.B.; Çetin, R.; Devrim, E.; Kılıçoğlu, B.; Avcı, A.; Durak, İ. Effects of cyclosporine on oxidant/antioxidant status in rat ovary tissues: Protective role of black grape extract. Int. Immunopharmacol. 2005, 5, 1311–1315. [Google Scholar] [CrossRef]
  92. Hussein, S.A.; Elsenosi, Y.; Esmael, T.E.A.; Amin, A.; Sarhan, E.A.M. Evaluation of renoprotective effect of grape seed proanthocyanidin extract on Cyclosporine A-induced Nephrotoxicity by mitigating inflammatory response, oxidative stress and apoptosis in rats. Benha Vet. Med. J. 2020, 39, 167–172. [Google Scholar] [CrossRef]
  93. Ulusoy, S.; Ozkan, G.; Yucesan, F.B.; Ersöz, Ş.; Orem, A.; Alkanat, M.; Yuluğ, E.; Kaynar, K.; Al, S. Anti-apoptotic and anti-oxidant effects of grape seed proanthocyanidin extract in preventing cyclosporine A-induced nephropathy. Nephrology 2012, 17, 372–379. [Google Scholar] [CrossRef] [PubMed]
  94. Wongmekiat, O.; Thamprasert, K. Investigating the protective effects of aged garlic extract on cyclosporin-induced nephrotoxicity in rats. Fundam. Clin. Pharmacol. 2005, 19, 555–562. [Google Scholar] [CrossRef] [PubMed]
  95. Liu, H.; Wu, C.; Wang, S.; Gao, S.; Liu, J.; Dong, Z.; Zhang, B.; Liu, M.; Sun, X.; Guo, P. Extracts and lignans of Schisandra chinensis fruit alter lipid and glucose metabolism in vivo and in vitro. J. Funct. Foods 2015, 19, 296–307. [Google Scholar] [CrossRef]
  96. El Daly, E.S. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. J. Pharm. Belg. 1998, 53, 87–93, discussion 93. [Google Scholar] [PubMed]
  97. Badary, O.A.; Nagi, M.N.; Al-Shabanah, O.A.; Al-Sawaf, H.A.; Al-Sohaibani, M.O.; Al-Bekairi, A.M. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can. J. Physiol. Pharmacol. 1997, 75, 1356–1361. [Google Scholar] [CrossRef]
  98. Muckensturm, B.; Foechterlen, D.; Reduron, J.-P.; Danton, P.; Hildenbrand, M. Phytochemical and chemotaxonomic studies of Foeniculum vulgare. Biochem. Syst. Ecol. 1997, 25, 353–358. [Google Scholar] [CrossRef]
  99. Owen, R.; Haubner, R.; Hull, W.; Erben, G.; Spiegelhalder, B.; Bartsch, H.; Haber, B. Isolation and structure elucidation of the major individual polyphenols in carob fibre. Food Chem. Toxicol. 2003, 41, 1727–1738. [Google Scholar] [CrossRef]
  100. Cook, J.A.; VanderJagt, D.J.; Pastuszyn, A.; Mounkaila, G.; Glew, R.S.; Millson, M.; Glew, R.H. Nutrient and chemical composition of 13 wild plant foods of Niger. J. Food Compos. Anal. 2000, 13, 83–92. [Google Scholar] [CrossRef]
  101. Hsu, B.; Coupar, I.M.; Ng, K. Antioxidant activity of hot water extract from the fruit of the Doum palm, Hyphaene thebaica. Food Chem. 2006, 98, 317–328. [Google Scholar] [CrossRef]
  102. Calder, P.C. Omega-3 fatty acids and inflammatory processes: From molecules to man. Biochem. Soc. Trans. 2017, 45, 1105–1115. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  103. Méndez, L.; Medina, I. Polyphenols and fish oils for improving metabolic health: A revision of the recent evidence for their combined nutraceutical effects. Molecules 2021, 26, 2438. [Google Scholar] [CrossRef] [PubMed]
  104. Priyamvada, S.; Priyadarshini, M.; Arivarasu, N.; Farooq, N.; Khan, S.; Khan, S.A.; Khan, M.W.; Yusufi, A. Studies on the protective effect of dietary fish oil on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney. Prostaglandins Leukot. Essent. Fatty Acids 2008, 78, 369–381. [Google Scholar] [CrossRef] [PubMed]
  105. Ali, B.; Bashir, A. Effect of fish oil treatment on gentamicin nephrotoxicity in rats. Ann. Nutr. Metab. 1994, 38, 336–339. [Google Scholar] [CrossRef]
  106. Cid, T.P.; Garcıa, J.C.; Alvarez, F.C.; De Arriba, G. Antioxidant nutrients protect against cyclosporine A nephrotoxicity. Toxicology 2003, 189, 99–111. [Google Scholar]
  107. Klawitter, J.; Klawitter, J.; Schmitz, V.; Brunner, N.; Crunk, A.; Corby, K.; Bendrick-Peart, J.; Leibfritz, D.; Edelstein, C.L.; Thurman, J.M. Low-salt diet and cyclosporine nephrotoxicity: Changes in kidney cell metabolism. J. Proteome Res. 2012, 11, 5135–5144. [Google Scholar] [CrossRef]
  108. Martin, W.F.; Armstrong, L.E.; Rodriguez, N.R. Dietary protein intake and renal function. Nutr. Metab. 2005, 2, 25. [Google Scholar] [CrossRef] [Green Version]
  109. Pons, M.; Plante, I.; LeBrun, M.; Gourde, P.; Simard, M.; Grenier, L.; Thibault, L.; Labrecque, G.; Beauchamp, D. Protein-rich diet attenuates cyclosporin A-induced renal tubular damage in rats. J. Ren. Nutr. 2003, 13, 84–92. [Google Scholar] [CrossRef]
  110. Musumeci, G.; Trovato, F.M.; Pichler, K.; Weinberg, A.M.; Loreto, C.; Castrogiovanni, P. Extra-virgin olive oil diet and mild physical activity prevent cartilage degeneration in an osteoarthritis model: An in vivo and in vitro study on lubricin expression. J. Nutr. Biochem. 2013, 24, 2064–2075. [Google Scholar] [CrossRef]
  111. Thakur, L.; Ghodasra, U.; Patel, N.; Dabhi, M. Novel approaches for stability improvement in natural medicines. Pharmacogn. Rev. 2011, 5, 48–54. [Google Scholar] [CrossRef] [Green Version]
  112. Seeff, L.B.; Bonkovsky, H.L.; Navarro, V.J.; Wang, G. Herbal products and the liver: A review of adverse effects and mechanisms. Gastroenterology 2015, 148, 517–532.e3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  113. Bunchorntavakul, C.; Reddy, K. Herbal and dietary supplement hepatotoxicity. Aliment. Pharmacol. Ther. 2013, 37, 3–17. [Google Scholar] [CrossRef] [PubMed]
  114. Sparks, E.; Zorzela, L.; Necyk, C.; Khamba, B.; Urichuk, L.; Barnes, J.; Vohra, S. Study of Natural products Adverse Reactions (SONAR) in children seen in mental health clinics: A cross-sectional study. BMJ Paediatr. Open 2020, 4, e000674. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Possible mechanisms of cyclosporine A nephrotoxic effects [13,14,15].
Figure 1. Possible mechanisms of cyclosporine A nephrotoxic effects [13,14,15].
Molecules 27 07771 g001
Figure 2. Proposed mechanisms of CA oxidative stress-induced reno-toxicity.
Figure 2. Proposed mechanisms of CA oxidative stress-induced reno-toxicity.
Molecules 27 07771 g002
Figure 3. Chemical structures of natural metabolites tested for reno-protective potential.
Figure 3. Chemical structures of natural metabolites tested for reno-protective potential.
Molecules 27 07771 g003
Figure 4. Different classes of natural products protect against CA-induced nephrotoxicity.
Figure 4. Different classes of natural products protect against CA-induced nephrotoxicity.
Molecules 27 07771 g004
Table 1. List of natural compounds evaluated for protective effects against CA-induced renal injury.
Table 1. List of natural compounds evaluated for protective effects against CA-induced renal injury.
Compound Name/ClassM.F.M.W.Plant/Name (Organ, Family)Ref.
Terpenoids
ThyomquinoneC10H12O2164Nigella sativa (Ranunculaceae)[23]
Oleanolic acidC30H48O3456Olea europaea (Oleaceae)[24]
Lignans
Schisandrin BC23H28O6400Schisandra chinensis (Schisandraceae)[25]
Carotenoids
LycopeneC40H56536Psidium guajava (Myrtaceae)
Solanum lycopersicum (Solanaceae)
[26]
Organo-sulphur
S-allylcysteine C6H11NO2S161Allium sativum (Amaryllidaceae)[27]
Flavonoids
NaringeninC15H12O5272Citrus fruits (Rutaceae)[28]
NaringinC27H32O14580Citrus fruits (Rutaceae)[29]
CatechinC15H14O6290Camellia sinensis (Theaceae)[30]
Epigallocatechin gallateC22H18O11458Camellia sinensis (Theaceae)[31]
SilibininC25H22O10482Silybum marianum L. (Asteraceae)[32]
Phenolics
CurcuminC21H20O6368Curcuma longa (Zingiberaceae)[33]
Ellagic acidC14H6O8302Punica granatum (Punicaceae)[34,35]
Caffeic acid phenethyl esterC17H16O4284Propolis[36]
ResveratrolC14H12O3228Vitis vinifera (Vitaceae)[37]
M.F.: molecular formula; M.W.: molecular weight.
Table 2. Protective effects of natural compounds on CA-induced renal injury.
Table 2. Protective effects of natural compounds on CA-induced renal injury.
CompoundExperimental ModelIntervention
(Dose, Route/Duration of Administration)
Studied ParameterPharmacological Outcomes/EffectsReferences
Thymoquinone Male Wister rats Four groups
Control: vehicle
TQ: TQ 10 mg/kg, orally
TQ+CA: TQ (10 mg/kg, orally)/1 week then CA (10 mg/kg, I.P.)/5 days with continuing TQ
CA: 10 mg/kg, I.P./5 days
Treatment duration: 28 days
Serum creatinine
Serum cystatin C
Blood glucose
Concomitant administration of TQ with CA ↓ serum cystatin and blood glucose levels
TQ prevented the major structural changes in both glomerular and tubular components induced by CA
[23]
White male albino rats Three groups
Control (no drugs)
CA: CA 25 mg/kg/day/orally/21 days
TQ protected + CA: TQ (10 mg/kg/day, orally) for 7 days before and during CA (25 mg/kg/day/orally) treatment
Treatment duration: 21 days
Serum urea and creatinine
L-MDA and GSH levels
CAT activity
NF-kB and PAI-1 expression levels
Caspase-3
p53
Bcl-2
TQ ↓ caspase-3 and p53 and ↑ Bcl-2 gene expressions
TQ ↓ NF-κB and PAI-1 gene expressions
TQ ↓ L-MDA level and ↑ GSH level and CAT activity
TQ ↓ urea and creatinine values
[40]
Oleanolic acid (OA)Five-week-old male ICR miceFour groups
Control: 1 mL olive oil/kg/daily, SC
VH + OA: 1 mL olive oil/kg/daily, SC then OA (25 mg/kg/daily I.P. for one week)
CA: CA 30 mg/kg/ daily, SC
CA + OA: CA (30 mg/kg/ daily, SC) + OA (25 mg/kg/daily I.P.)
Treatment duration: 28 days
Renal functional parameters
Morphological changes
Nrf-2, Keap1, and antioxidant defense system
Renal apoptosis
OA ↓ tubulointerstitial fibrosis and inflammation
OA ↓ urinary 8-OHdG and 8-iso-PGF2α levels
OA ↑ ratio of nuclear/total Nrf2 and enhanced HO-1 expression
OA ↓ expression of Bcl-2 and ↑ Bax and cleaved caspase-3
[24]
Schisandrin B (ScB)HK-2 cell line Pretreatment with ScB (2.5, 5.0, and 10.0 μM) for 12 h, then CA (10 μM) for 24 h ROS, Nrf2, Bax, Bcl-2, LC3, Beclin1, and p62 ScB ↓ ROS and LDH levels
ScB ↑ ΔΨm and GSH levels
ScB activated Nrf2
ScB ameliorated apoptosis induced by CA
ScB abrogated autophagy activation stimulated by CA
[13]
ScB (2.5, 5, and 10 M) for 30 min and then exposed to CA (10 M) for 24 h LDH release
Cell viability
Cellular apoptosis
GSH and ATP levels
ROS levels
ScB ↓ LDH release and ↑ cell
viability
ScB ↓ number of early apoptotic cells
ScB ↑ GSH and ATP levels
[41]
KM adult male mice Four groups
Control: olive oil (10 mL/kg, gavage) and then olive oil (2 mL/kg, SC)
ScB: 20 mg/kg, gavage, and then olive oil (2 mL/kg, SC)
CA: olive oil (10 mL/kg, gavage), and then CA (30 mg/kg, SC)
CA+ScB: ScB (20 mg/kg, gavage), and then CA (30 mg/kg, SC)
Treatment duration: 28 days
LDH release
Cellular apoptosis
GSH and ATP levels
ROS levels
GSH level
MDA level
↓ BUN and creatinine levels
↑ GSH and ↓ MDA levels
ScB markedly improved the structural changes induced by CA
[41]
LycopeneMale Swiss albino ratsFour groups
Control: saline solution, I.P.
Lyc: 40 mg/kg/day, oral gavage
CA: 15 mg/kg/day, I.P. for 10 days
LYC + CA: LYC (40 mg/kg/day, oral gavage for 5 days then CA (15 mg/kg/day, I.P. for 10 days) concomitantly with LYC
Treatment duration: 15 days
Serum creatinine and urea levels
MDA level
GSH-Px activity
SOD activity
LYC ↓ urea and creatinine levels
LYC restored GSH and ↓ MDA levels
LYC ↑ Gpx and SOD activities
LYC markedly improved CA-induced structural changes
[26]
Adult male Sprague Dawley rats Four groups
Control: 0.5 mL isotonic saline + 0.5 mL corn oil, SC for 21 days
CA: 15 mg/kg/day CA + 0.5 mL corn oil, SC for 21 days
LYC: 10 mg/kg/day LYC + 0.5 mL corn oil, SC for 21 days
CA+LYC: 10 mg/kg/day LYC + 15 mg/kg/day CA, SC for 21 days
Treatment duration: 21 days
TBARs level
GSH level
GSH-Px activity
CAT activity
Plasma creatinine, urea, Na+ and Ca++
LYC ↓ plasma creatinine and
urea levels
LYC normalized TBARs
LYC ↑ GSH-Px and CAT activity
LYC alleviated CA-induced histological changes
[42]
S-Allylcysteine (SAC) Wistar male albino rats Five groups
Control: oral saline
CA: 25 mg/kg/day, orally
CA+SAC: CA 25 mg/kg b.w./day with SAC 100 mg/kg/day, I.P.
CA+ Vit. C: 25 mg/kg/day with vitamin C 100 mg/kg/day, orally
SAC: 100 mg/kg/day I.P.
Treatment duration: 21 days
Serum renal markers
urea, uric acid, creatinine, and BUN
Renal enzymes (ALP, ACP, AST, ALT, and LDH)
Antioxidants enzymic (SOD, CAT, GPx, and GR) non-enzymic (GSH, vits C and E)
Expressions of NF-kB, iNOS, and MMP-2
SAC prevented alteration in urea, uric acid, creatinine, and BUN induced by CA the same as vit C
SAC ↓ the rise in LPO induced by CA compared with vit. C
SAC ↑ antioxidants levels compared with vit. C
SAC ↓ renal injury and inflammation
SAC suppressed the expressions of NF-kB, MMP-2, and iNOS
[27]
CurcuminAdult male ratsThree groups
Control
Curcumin+CA (15 mg/kg with CA)
CA: 20 mg/kg, SC/5 days
Treatment duration: 21 days
Morphological changes
Glutathione S-transferase (GST) immune expression
Serum urea and creatinine
Curcumin showed promising protective effect against CA-induced nephrotoxicity in rats through improving histological parameters, antioxidant effect, and renal dysfunction[33,43,44]
Five groups
Vehicle: olive oil SC + 0.5% CMC orally for 21 days
CA: 20 mg/kg/day, SC in olive oil for 21 days
CA+ Curcumin: CA (20 mg/kg/day SC) + Curcumin (5, 10, or 15 mg/kg for 21 days
Treatment duration: 21 days
Oxidative stress in kidney tissues (TBARS, GSH, SOD, and CAT)Curcumin ameliorated renal dysfunction through decreasing TBARS and increasing levels of antioxidant enzymes (GSH, SOD, and CAT)[45]
Resveratrol (RES) Male albino Wistar rats Eight groups
Control
Vehicle: olive oil (SC) + saline (p.o.) for 21 days
CA: CA (20 mg/kg, SC) in
olive oil for 21 days
RES 2 mg+CA: RES (2 mg/kg, p.o.) 24 h before CA and continued along with CA for 21 days
RES 5 mg+CA: RES (5 mg/kg, p.o.) 24 h before CA and continued along with CA for 21 days
RES 10 mg+CA: RES (5 mg/kg, p.o.) 24 h before CA and continued along with CA for 21 days
RES+ L-NAME: RES (5 mg/kg,
p.o.) and L-NAME (10 mg/kg, I.P.) 24 h before CA and continued along with CsA for 21
days
L-NAME: L-NAME (10 mg/kg, I.P.) 24 h before CA and continued along with CA for 21 days
Treatment duration: 21 days
Renal oxidative stress
Renal functions
Tissue and urine nitrite and
nitrate levels
Renal lipid peroxides and antioxidant enzymes
Renal histology
RES (5, 10 mg/kg) improved renal dysfunction, renal and tissue NO levels, and oxidative stress
Co-administration of L-NAME blocked RES protective effect indicating that RES effect is NO-dependent
[37]
Naringin (NG) Male albino Wistar rats Four groups
Control: olive oil
CA: CA 25 mg/kg for 21 days
NG: NG 40 mg/kg/orally
CA+NG: CA-treated group concurrently with NG daily (oral dose 40 mg/kg)
Treatment duration: 21 days
Lipid peroxides (TBARS) and hydroxyl radical (OH)
SOD, CAT, GSH, and vitamins C, E, and A
NG significantly ↓ oxidative stress and restored the levels of enzymic and non-enzymic antioxidants in renal tissues[29]
Caffeic acid phenethyl ester (CAPE)Wistar albino female ratsFour groups
Control: 0.5 mL normal saline
CA: CA (15 mg/kg/day SC in saline for 10 days)
CAPE: CAPE 10 µM/kg/day, I.P. in saline for 11 days
CAPE+CA: CAPE 10 µM/kg/day, I.P. for 11 days, while CA was administered concurrently for 10 days
Treatment duration: 11 days
MPO activity
Lipid peroxidation
SOD and CAT
CAPE prevented increase in MDA
CAPE ↑ CAT, but did not affect MPO and SOD
[36]
Catechin (CATC)Wistar rats (both sexes)Five groups
Control: olive oil (S.C) and 0.5% sodium CMC orally
CA: CA (20 mg/Kg/day/SC, for 21 days)
CA+50mg CATC: CA (20 mg/Kg/day, SC)+ CATC (50 mg/kg/day P.O) for 21 days
CA+100mg catechin: CA (20 mg/Kg/day, SC)+ CATC (100 mg/kg/day, P.O)
CATC: CATC (100 mg/kg/day, P.O.)
Treatment duration: 11 days
Body weight, water intake, food intake, urine output and kidney weight, oxidative stress markers (renal MDA, glutathione, renal antioxidant enzymes, such as SOD, catalase)CATC ↑ body weight by administration of CATC (100 mg/kg/day) with CA for 21 days
CATC ↑ renal function by ↓ serum creatinine, blood urea nitrogen, and ↑ creatinine and urea clearance
CATC (50 mg/kg/day) restored only increased serum creatinine levels
[22]
Epigallocatechin gallate PLGA NPsMale Sprague Dawley ratsSix groups
All receiving CA (15 mg/kg/day orally) and EGCG (50 mg/kg)
Control
Sandimmune neural (CA)
SN+EGCG (I.P.) daily
SN+EGCG (oral) daily
SN+EGCG (I.P.) once in three days
SN+EGCG (I.P.) once in three days (blank particles)
Treatment duration: 30 days
BUN, PC, MDA, GSH, and total proteins
Histological studies
↓ BUN and PC levels (I.P. injection of EGCG along with SN)
Co-treatment of EGCG NPs as equally effective as I.P. administration
EGCG solution prevented histological damage induced by SN treatment
EGCG NPs prevented renal damage, artial glomerular collapse, and tubular damage
[38]
Ellagic acidAdult male Sprague Dawley ratsFour groups
Control: 0.5 mL isotonic saline+ 0.5 mL slightly alkaline solution, SC for 21 days
CA: 15 mg/kg+0.5 mL slightly alkaline solution S.C for 21 days
Ellagic acid: 0.5 mL isotonic saline+10 mg/kg ellagic acid SC for 21 days
CA+ellagic acid, SC for 21 days
Treatment duration: 21 days
MDA, GSH, GSH-Px, and CAT activities
Histopathological examination
No significant change in GSH level
Slight decrease in MDA level
Ellagic acid ↑ decreased GSH-Px activity and CAT activity due to CA intake
Ameliorated tubular necrosis, tubular degeneration, and desquamation, thickening basement membrane, inter-tubular haemorrhagia, and tubular dilatation
[46]
SilibininFemale Wistar ratsFour groups
Control: standard chow and I.P. injection of placebo solution
Silibinin: standard chow and I.P. silibinin 5 mg/kg
CA: 30 mg/kg I.P.
CA+Silibinin: I.P. silibinin and CA
Treatment duration: 15 days
Urea, creatinine, total protein, and GFR
Lipid peroxidation
Histopathological examination
Total MDA
Silibinin ↓ CA-induced LPO without protective effect on GFR[47]
Naringenin (NGA) and VOO Four groups
Control: saline
CA: 25 mg/kg/day for 45 days
CA+NGA: NGA 100 mg/kg/day+ CA 25 mg/kg/day for 45 days
CA+VOO: VOO 1.25 mL/kg/day + CA 25 mg/kg/day for 45 days
Treatment duration: 45 days
Body and kidney weights
Cyclosporine blood level
Renal biochemical markers
Redox status
VOO and NGA ↑ body and kidney weights
VOO and NGA ↓ CA blood level
VOO and NAR ↓ serum creatinine and urea levels
VOO and NGA ↑ CAT, peroxidase, GSH, and SOD
VOO and NGA ↓ MDA and NO
[28]
Provinol (PV)
mixture of polyphenolics: proanthocyanidins, total anthocyanins, free anthocyanins, catechin, hydroxycinnamic acid, and flavonols
Adult male Wistar ratsFour groups
Control: olive oil, SC
PV: PV (40 mg/kg/day orally)
CA: CA (15 mg/kg/day/SC)
PV+CA: PV and CA simultaneously
Treatment duration: 21 days
Systolic blood pressure
Creatinine clearance
Oxidative stress
NF-kB
NO-synthase
PV ↓ oxidative stress and ↑ iNOS and NF-kB expression induced by CA[48]
Ninety-day-old virgin female and male Wistar ratsFour groups
Control: olive oil, SC
PV: PV (40 mg/kg/day/orally)
CA: CA (15 mg/kg/day/SC)
CA+PV: CA and PV I.P. daily for 21 days of pregnancy
Treatment duration: 21 days
Histopathological and immunohistochemical evaluations
Stereological analysis for glomerular volume and size
iNOS and MMP2
PV ↓ oxidative stress and iNOS expression via NF-kB pathway PV protected on CA-induced structural and functional alterations of the kidney[49]
Adult male Wistar ratsFour groups
Control: olive oil (SC)
CA: CA (15 mg/kg/day/ SC) for 21 days
PV: (40 mg/kg/day, orally)
PV+CA: PV concurrently during CA injections for 21 days
Treatment duration: 21 days
Body weight, SBP, serum creatinine, urinary protein concentration, GFR, creatinine clearance, renal GSH contentPV prevented CA-induced decrease in body weight and increase in SBP
PV ↓ CA-induced depletion of GSH
PV restored morphological and biochemical alterations
[50]
Table 3. Plants extracts and/or faction effects on CA-induced renal injury.
Table 3. Plants extracts and/or faction effects on CA-induced renal injury.
Name of Plant (Organ, Family)/DietExtract/Fraction (Major Constituents)Intervention
(Dose, Route/Administration Duration)
Studied ParameterPharmacological Outcomes/EffectsReference
Sargassum wightii (Sargassaceae)Sulphated polysaccharides (SWSPs)Male albino Wistar rats
Four groups
Control: olive oil
SWSP: SWSP (5 mg/kg/b.w., S.C.)
SWSP+CA: SWSP (5 mg/Kg/b.w., SC)/3 weeks then CA (25 mg/kg/b.w., orally)/21 days
CA: CA (25 mg/kg/b.w., orally/21 days)
Treatment duration: 28 days
Glycosaminoglycans
Protein content
Creatinine clearance
Lysosomal enzymes
Serum and urinary creatinine
Protein-bound carbohydrates
SWSP ↑ creatinine clearance
SWSP ↓ lysosomal enzyme activity
SWSP ↓ glycoproteins levels
SWSP ↓ glycosaminoglycanuria SWSP ↓ proteinuria
SWSP attenuated CA-induced histological changes
[69]
Male albino Wistar rats
Four groups
Control: olive oil alone
CA: 25 mg/kg/b.w., orally/21 days
SWSP: 5 mg/Kg/b.w., SC
SWSP+CA: SWSP (5 mg/Kg/b.w., SC)/3 week then CA (25 mg/kg/b.w., orally)/21 days.
Treatment duration: 28 days
Enzymes (ALP, NAG, LDH, and c-GT)
Mitochondrial oxidative stress (ROS, SOD, GPx, and GSH)
Lipid peroxidation (MDA)
TCA cycle enzymes
Enzyme complexes of electron transport chain
SWSP ↓ ROS level and lipid peroxidation
SWSP ↑ antioxidant defense
system
SWSP ↑ activities of tricarboxylic acid cycle and electron transport chain enzymes and ↓ urinary enzymes
SWSP ameliorated mitochondrial swelling
[68]
Dietary fish oil (DFO) White male albino rats
Four groups
Control: no drugs
DFO: DFO (270 mg/kg/day, orally)
CA: CA (25 mg/kg/day orally for 21 days)
DFO+CA: DFO for 21 days before, 21 days concurrently during CA and 21 days later
Treatment duration: 63 days
Serum glucose, TP, albumin, and lipid profile (TC, TAGs, and PLs)
Renal function (urea, UA and Cr, and electrolytes (Na and K))
Inorganic phosphorus and haptoglobin levels LDH and GGT activities
MDA, GSH, NO, and TOA levels
CAT, SOD, and Gpx activities
DFO restored urea, uric acid, creatinine, and haptoglobin levels
DFO normalized lipid profile, LDH, CGT, serum protein, and electrolytes
DFO ↓ peroxidative levels and ↑ CAT, SOD, and GPx activities
DFO ↑ GSH and TAC levels
[40]
Probiotic formulation LOBUN Male Wistar rats
Four groups
Normal: olive oil
Control: CA (20 mg/kg/day, SC) for 15 days
CA+LOBUN: CA (20 mg/kg/day, SC) for 15 days; LOBUN (500 mg/kg/p.o./twice daily) from 15th to 28th day
CA+LOBUN: CA (20 mg/kg/day, SC) for 15 days; LOBUN (500 mg/kg p.o./thrice daily) from 15th to 28th day
Treatment duration: 28 days
BUN, serum Cr, serum
UA, total serum and urine proteins, and urine K and Na
LOBUN ↓ serum BUN, serum Cr, serum UA and ↑ total serum protein
LOBUN ↓ urine protein concentration and ↑ Na and K
LOBUN ↓ inflammatory infiltration and vacuolization
[80]
Zingiber officinale (Zingebraceae) 80% rhizome acetone extract rich in polyphenols (GP) Male Wistar rats
Five groups
Control: distilled H2O
CA: CA (50 mg/kg, p.o.) for 10 consecutive days
CA+GP: CA (50 mg/kg, p.o.) + GP (100 mg/kg, p.o.) for 21 days
CA+GP: CA (50 mg/kg, p.o.) +GP (200 mg/kg, p.o.) for 21 days
CA+GP: CA (50 mg/kg, p.o.) + GP (400 mg/kg, p.o.) for 21 days
Treatment duration: 21 days
Percentage of body weight
Kidney weight changes
Food consumption, water intake, and urine volume
Creatinine clearance
Electrolyte assays
Oxidative stress
GP attenuated kidney injury caused by CA through improvement of plasma and urine levels of creatinine, urea, Na+ and K+ electrolyte balance, as well as creatinine clearance
GP improved feeding pattern, relative kidney weight, and oxidative stress
[76]
Date pits (DPEs)Aqueous extractMale Wister albino rats
Four groups
Control: 0.5 mL of NaCl/ day for
28 days
CA: CA (15 mg/kg/day, SC) for 28 days
DPE+CA: DPE (4 mL/ kg/ day)+CA (15 mg/kg/d) for 28 days
DPE+CA: DPE (6 mL/ kg/ day, orally)+CA (15 mg/kg/ day) for 28 days
Treatment duration: 28 days
Serum Cr, BUN, UA, sodium, potassium, total protein, and albumin levels
MDA, GSH, and CAT activities
Histological changes
DPE ameliorated all measured parameters
DPE protected against CA-induced histopathological changes
DPE ↓ MDA and ↑ GSH and CAT activities
[77]
Spinacea oleracea1%n-hexane extract (SOH) Rats
Four groups
Control: olive oil (2 mL/kg, I.P., 7 days)
CA: CA (20 mg/kg in 2 mL olive oil I.P., 7 days)
SOH+CA: SOH (0.5 mL concomitantly with CA (20 mg/kg in 2 mL olive oil, I.P.) from days 7 to 14
SOH: SOH (0.5 mL orally for 14 days)
Treatment duration: 14 days
Histological changes SOH significantly restored all
disturbed histologic parameters
SOH ↓ glomerular diameter
[78]
GinsengKorean red ginseng extract (KRG) Mice
Eight groups
VH: olive oil (5 mL/kg, SC daily) and oral sterile water for 4 weeks
VH+KRG 0.2: Olive oil (5 mL/kg, SC) + KRG (0.2 g/kg, orally) for 4 weeks
VH+KRG 0.4: Olive oil (5 mL/kg, SC) + KRG (0.4 g/kg, orally) for 4 weeks
VH+KRG 0.8: Olive oil (5 mL/kg, SC) + KRG (0.8 g/kg, orally) for 4 weeks
CA: CA (30 mg/kg, SC) and oral sterile water for 4 weeks
CA+KRG 0.2: CA (30 mg/kg, SC) + KRG (0.2 g/kg, orally) for 4 weeks
CA+KRG 0.4: CA (30 mg/kg, SC) + KRG (0.4 g/kg, orally) for 4 weeks
CA+KRG 0.8: CA (30 mg/kg, SC) + KRG (0.8 g/kg, orally) for 4 weeks
Treatment duration: 28 days
Assessing renal function and pathology, mediators of inflammation, tubulointerstitial fibrosis, and apoptotic cell death
Effect on proximal tubular cells (HK-2) by in vitro model
Assessing 8-OHdG levels in 24 h urine, tissue sections, and culture media
KRG ↓ serum Cr and BUN
KRG ↑Cr clearance
KRG ↓ proinflammatory and profibrotic molecules as iNOs, cytokines, TGF-β1, and TGF-β1-inducible gene h3 and apoptotic cell death
In vitro studies, KRG ↑ protection against CA-induced morphological changes, cytotoxicity, inflammation, and apoptotic cell death
KRG ↓ 8-OHdG level in urine and culture supernatant
[79]
Black grape/garlic extractDried fruit (BG)/aqueous extract (GAE)Sprague Dawley rats
Six groups
CA: CA (25 mg/kg/day, orally) for 10 days, with food supplementation (3 days before CA treatment and continued during the study period (13 days))
Control
CA: CA (25 mg/kg/day, orally) for 10 days
CA+ BG: BG (25 g/kg/day with diet)
CA+GAE: GAE (20 mL/kg/day with drinking H2O)
BG: BG (25 g/kg/day with diet)
GAE: GAE (20 mL/kg/day with drinking H2O)
Treatment duration: 13 days
Oxidant (XO and MDA) and antioxidant (SOD, GSH-Px, and CAT) enzymes
Histopathological changes
BG and GAE produced no changes in XO, SOD, and GSH-Px activities
BG and GAE ↓ MDA level and CAT activity
BG and GAE ameliorated glomerular sclerosis tubular necrosis and interstitial fibrosis
[81]
Green teaLyophilized aqueous extract (GTE)White male albino rats
Four groups
Control
GTE: GTE (3 %W/V) for 9 weeks
CA: CA (25 mg/kg/orally/day) for 21 days
GTE+CA: GTAE (3% W/V) for 21 days before CA, then for 21 days concomitant with CA followed by 21 days later
Treatment duration: 63 days
Serum glucose, TP, albumin, TC, TAGs, PLs, urea, UA, Cr, Na, K, inorganic phosphorus, LDH, GGT.
MDA, GSH, NO, TAO, CAT, SOD, and GPX
GTE improve renal function and
↓ peroxidative levels
GTE ↑ renal tissues antioxidant by enhancing CAT, SOD, GPX, and TAC activities
GTE restored elevated glucose, lipid profile, urea, UA, Cr, LDH, and GGT.
GTE reversed ↑ in serum proteins and electrolyte to normal range
[82]
Lyophilized aqueous extractSprague Dawley rats
Six groups
Control
CA: CA (20 mg/kg/day, I.P.) for 21 days
GTE0.5+CA: GTE (0.5% with drinking water, 4 days before and 21 days concurrently with CA
GTE0.5+CA: GTE (1% with drinking water, 4 days before and 21 days concurrently with CA
GTE0.5+CA: GTE (1.5% with drinking water, 4 days before and 21 days concurrently with CA
GTE: GTE (1.5% with water) for 25 days
Treatment duration: 21 days
Glucose, Cr, BUN, serum UA, and Cr levels
GSH and TBARS
Enzyme activities: CAT, SOD, GPx, GR, GST, NAG, β-GU, and AP
GTE prevented TBARS regeneration
GTE ↓ CA-induced renal dysfunction as indicated by ↓ serum Cr, BUN, UA, and urinary excretion of glucose
GTE ↑ reduced glutathione content and activity of antioxidant enzymes in the kidney homogenate
GTE ↓ activity of lysosomal enzymes; NAG and AP
[83]
PropolisEthanol extractSprague Dawley rats
Four groups
Control: no supplement
CA: CA (15 mg/kg/day SC)
Propolis (100 mg/kg/day, gavage)
CA+Propolis: CA (15 mg/kg/day SC)
+ Propolis (100 mg/kg/day, gavage)
Treatment duration: 21 days
Serum cortisol, glucose, albumin, globulin, TP, urea, TAGs, HDL, VLDL, LDL, TC, Cr, AST, and ALT valuesPropolis ↓ improved CA-induced BW reduction
Propolis ↓ cortisol, AST, ALT, urea, and MDA levels in kidney
Propolis ↑ CAT and GSH activities
[84]
Spirulina
(algae, Arthrospira platensis)
Male Sprague Dawley rats
Eight groups
Control
R: single dose of whole-body gamma irradiation (6.5 Gy)
CA: CA (25 mg/kg, I.P.) for 10 days
CA+R: CA for 10 days, then exposed to gamma radiation on the last day
Sp: Sp (1 g/kg, intragastric gavages for 15 consecutive days)
Sp+R: Sp for 15 days before irradiation
Sp+CA: Sp for 5 days before and 10 days concomitant with CA
Sp+CA+R: Sp for 5 days before and 10 days concomitant with CA injection and exposed to gamma radiation
Treatment duration: 15 days
Serum creatinine, urea, glucose, albumin, protein, and lipid profile as well as GSH, TBARS, nitrite, and SOD activities
Trace elements (Zn and Mg)
Caspase-3 expression
Histopathological changes
Sp ↓ serum creatinine, urea, and glucose levels of CA-administrated rats
Treatment of irradiated CA- administrated rats with Sp ↓ serum creatinine and urea
Sp ↓ serum albumin and protein levels of R group (20 and 17%, respectively), CA group (20 and 13%, respectively), and CA + R group (28 and 21%, respectively)
Sp ↓ Zn and ↑ Mg content of kidney
[85]
Cordyceps cynensis (CS)Pharmaceutical
product
Concurrent administration of Cordyceps sinensis in CA-treated kidney-transplanted recipients. Each recipient was given CA (5 mg/kg/day for 15 days)
Control: placebo (glucose) 3 g
CS: Cordyceps sinensis 3g simultaneously
Treatment duration: 15 days
Blood creatinine, urea, and NAG SC ↓ creatinine, urea, and NAG
SC protected the proximal tubular function and ameliorated renal hemodynamics
[86]
Fennel, carob, doum
(FE, CA, DO)
Powdered FE seeds, CA pods, and DO fruit (17, 18, and 21 g/kg, respectively) were added to the experimental animal’s diet Female Sprague Dawley rats
Six groups
Control: injected with corn oil daily for 7 days
CA: CA (50 mg/kg/day in corn oil for 1 week)
CA+FE, CA, and DO: injected CA for 7 days then FE, CA, and DO and mixture of them was added to the diet of these groups, respectively
Treatment duration: 45 days
Creatinine levels in serum and urinary samples, serum ammonia, TGF-β, TNFα, NAG, and β2MG
Histopathological examination
FE, CA, and DO mixture ↓ serum creatinine, urinary creatinine,
and serum ammonia levels
They ↑ creatinine clearance
They ↓ urinary β2MG and NAG activity and ↓ levels of serum TNF-α and TGF-β
They significantly ameliorated functions and morphological structure of the kidney
[87]
Ipomea batates (LB)Aqueous extractMale rats
Four groups
Control: distilled water for 2 weeks, then olive oil, I.P. for 21 days
CA: distilled water for 2 weeks, then CA (25 mg/kg, I.P. in olive oil/21 days)
LB200 + CA: LB 200 mg/kg, orally) for 21 days, then CA
LB400 + CA: LB 400 mg/kg, orally) for 21 days, then CA
Treatment duration: 21 days
Oxidative stress biomarkers (MDA and SOD)
Cytokines (IL-1β and TNF-α)
Kidney function (BUN, UA, Cr)
Na+ and K+serum levels Histopathological studies
LB ↓MDA and ↑SOD activity
LB ↓ TNF-α and IL1-β
LB ↓ BUN, UA, and Cr
LB ↑ ionic Na+ level and ↑ ionic K+ level
[88]
Nigella sativa oil (NSO)Fixed oilMale Wistar albino rats
Four groups
Control: sunflower oil (2 mL/kg/day, orally)
NSO: NSO (2 mL/kg orally/21 days)
CA: CA (25 mg/kg, orally/21 days)
CA + NSO: NSO (2 mL/kg orally) since the first day, while CA (25 mg/kg orally) for the last 21 days
Treatment duration: 21 days
Urine and serum Cr levels
Total (Cu-Zn, Mn) SOD activities
CAT, GSH-Px, and MDA
Kidney nitrite and nitrate levels
No significant amelioration of Cr levels and SOD activities for groups CA with NSO
NSO ↑ GSH-Px level
NSO ↓ MDA and NO levels
[89]
Schisandrae chinensis (SCE)Fruit 95% alcohol extractMale Sprague Dawley rats
Seven groups
Vehicle: olive oil (10 mL/kg) for 14 days
CA: CA (50 mg/kg) for 3 days
CA + SCE: 50 mg/kg CA + 216 mg/kg SCE for 3 days
CA group: 50 mg/kg CA for 7 days
CA + SCE: 50 mg/kg CA + 216 mg/kg SCE for 7 days
CA: 50 mg/kg CA for 14 days
CA + SCE: 50 mg/kg CA + 216 mg/kg SCE for 14 days
Treatment duration: 14 days
Cre and BUN
GSH, CAT, MDA, and SOD
Pathologic manifestations
SCE ↓ CRE and BUN levels
SCE ↑ GSH, CAT, and SOD and ↓ MDA
In the 14-day group, no glomerular balloon occlusions or vacuolar lesions were observed, and the tissues presented good renal characteristics
[90]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ibrahim, S.R.M.; Abdallah, H.M.; El-Halawany, A.M.; Mohamed, G.A.; Alhaddad, A.A.; Samman, W.A.; Alqarni, A.A.; Rizq, A.T.; Ghazawi, K.F.; El-Dine, R.S. Natural Reno-Protective Agents against Cyclosporine A-Induced Nephrotoxicity: An Overview. Molecules 2022, 27, 7771. https://doi.org/10.3390/molecules27227771

AMA Style

Ibrahim SRM, Abdallah HM, El-Halawany AM, Mohamed GA, Alhaddad AA, Samman WA, Alqarni AA, Rizq AT, Ghazawi KF, El-Dine RS. Natural Reno-Protective Agents against Cyclosporine A-Induced Nephrotoxicity: An Overview. Molecules. 2022; 27(22):7771. https://doi.org/10.3390/molecules27227771

Chicago/Turabian Style

Ibrahim, Sabrin R. M., Hossam M. Abdallah, Ali M. El-Halawany, Gamal A. Mohamed, Aisha A. Alhaddad, Waad A. Samman, Ali A. Alqarni, Akaber T. Rizq, Kholoud F. Ghazawi, and Riham Salah El-Dine. 2022. "Natural Reno-Protective Agents against Cyclosporine A-Induced Nephrotoxicity: An Overview" Molecules 27, no. 22: 7771. https://doi.org/10.3390/molecules27227771

Article Metrics

Back to TopTop